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ABSTRACT 
Abstract 
The main steroidogenic organs in mammals, the adrenal glands and gonads, arise from a 
common pool of mesodermal progenitor cells during embryogenesis. Precise gene 
regulation controls cell differentiation, growth, and homeostasis in the developing 
embryo and the adult. Disruptions of these spatiotemporal processes are linked to a 
variety of diseases, including developmental disorders, malignant transformations, and 
infertility. This dissertation focuses on the molecular mechanisms that regulate normal 
and neoplastic cell development in the adrenal cortex and testis of the mouse. 
 The initiation of gene transcription requires the binding of transcription factors to 
specific cis-regulatory elements within DNA. Methylation of cytosine residues affects 
transcription factor binding to these regulatory elements; hypermethylation results in 
condensed chromatin that is inaccessible to the transcriptional machinery, whereas 
hypomethylation is an indicator of active gene transcription. Alterations in DNA 
methylation have been linked to neoplasia. We used a novel method of genome-wide 
methylation profiling, termed Laser Capture Microdissection-Reduced Representation 
Bisulfite Sequencing, to characterize the changes in promoter methylation associated 
with gonadectomy-induced adrenocortical neoplasia in the mouse.  
 One of the genes upregulated during gonadectomy-induced adrenocortical 
neoplasia is Gata4, a transcription factor normally absent in the adult adrenal gland. To 
determine whether GATA4 directly modulates tumorigenesis we analyzed mice with 
germline or conditional loss-of-function mutations in this gene. GATA4 deficiency was 
associated with reduced tumor growth and decreased expression of sex steroidogenic 
markers. 
  GATA4 is expressed in testicular Leydig cells. To gain insight into the role of 
GATA4 in this cell type, we performed gene silencing experiments in a mouse Leydig 
cell tumor line (mLTC-1) and in primary mouse Leydig cells. Comprehensive analyses, 
including transcriptomic and metabolomic profiling, showed that Gata4 silencing was 
associated with diminished sex steroid production and impaired glycolysis.  
 Conditional deletion of Gata4 in another testicular somatic cell type, the Sertoli 
cell, has been reported to increase the permeability of the blood-testis barrier (BTB) and 
disrupt spermatogenesis in adult mice. To elucidate the molecular underpinnings of 
these phenotypic abnormalities, we performed Gata4 gene silencing experiments in an 
immortalized Sertoli cell line (TM4) and in primary mouse Sertoli cells. GATA4 
depletion was associated with altered expression of genes involved in BTB maintenance, 
including components of tight/adherens junctions (e.g., Tjp1, Cldn12) and the 
extracellular matrix (e.g., Lamc1, Col4a5). Gata4 gene silencing impaired the 
production of lactate, a key Sertoli cell-derived nutrient that is essential for proper 
spermatogenesis.  
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1. Review of the literature 
1.1 Gene regulation 
The genetic blueprint of life, needed for normal mammalian growth and development, is 
encoded by deoxyribonucleic acid (DNA). The translation of this genetic information 
facilitates the formation of a multi-cellular organism comprising more than 100 distinct 
cell types. The unique features of a cell, including its form, behavior, and identity, are 
determined by the expression of particular genes at specific times. 
Several levels of gene regulation are known to control the production or stability of 
a gene product. Firstly, chromatin structure dictates whether a given gene is available for 
transcription or not. Secondly, gene expression is determined by the availability and 
presence of transcription factors that bind to specific sequences of DNA and consequently 
initiate gene transcription. Additionally, expression is regulated through post-
transcriptional processing such as alternative splicing, translational control, mRNA 
stability, and cytoplasmic polyadenylation. 
1.1.1 Chromatin and DNA methylation  
Epigenetic mechanisms, which are independent of the DNA sequence, can change 
chromatin structure. These changes often arise through biochemical modifications of 
histones and DNA. DNA methylation, meaning the addition of a methyl group at cytosine 
residues of the DNA template, was the first epigenetic mechanism known to correlate with 
gene expression (1). The resulting 5-methylcytosine (5mC) is a general characteristic of 
chromatin states; extensive methylation of DNA is associated with condensed chromatin, 
whereas DNA sequences with low-level of DNA methylation are more loosely packed and 
thus accessible for transcriptional activation (Figure 1). Consequently, the promoter 
regions of actively transcribed genes are hypomethylated.  
DNA methylation patterns are heritable from one cell generation to the next and 
vary between cell types and distinct developmental stages. Most mammalian 5mC 
methylations occur at the cytosine of a cytosine-guanidine dinucleotide known as CpG (2). 
However, 5mC undergoes spontaneous deamination resulting in thymidine and a genome 
depleted of CpG dinucleotides (3). This deamination results in nearly 30,000 
unmethylated CpG-rich regions, known as CpG islands (CGIs) which are primarily 
located in gene promoters (4).  
DNA methylation is performed by a family consisting of four proteins known as the 
DNA methyltransferases (DNMTs) (2). Dnmt1 serves to maintain an existing DNA 
methylation pattern during replication. It only methylates those CpG dinucleotides of the 
nascent DNA strand that are paired with a methylated CpG of the parental DNA strand. 
Thus DNA methylation is transmitted from parent cell to daughter cells and the cellular 
identity is maintained. Global 5mC levels vary among different cell types and tissues and 
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are thought to be an important means by which cells maintain their identity through 
cellular divisions (5). 
The idea that DNA methylation serves a mechanistic function to silence genes 
emerged through the pioneering studies of Christman et al., who observed a correlation 
between hypomethylation of DNA and expression of globin genes in erythroleukemia 
cells (6). 5mC became fully accepted as a transcriptional regulator when global 
methylation and gene expression profiling showed that the methylation of CpGs upstream 
of genes resulted in their downregulation (7). 
 
Figure 1 DNA and histone modifications alter chromatin states. The accessibility of DNA to 
transcription factor machinery is determined by chromatin structure, which can vary as a 
consequence of DNA and histone modifications (e.g., DNA methylation and histone 
acetylation). Modified from (8). 
The importance of DNA methylation in normal development and health has been 
demonstrated using transgenic animal models, including Dnmt1 knockout mice, which die 
during embryonic development (9). Additionally the growing number of human diseases 
lined to aberrant 5mC formation or maintenance emphasize the essential role of DNA 
methylation for the normal function of mammalian cells (10). Aberrant DNA methylation 
is a hallmark of cancer cells (11, 12) and global hypomethylation in these cells can lead to 
abnormal activation of growth promoting genes (13, 14). Tumorigenesis can further be 
supported through hypermethylation of gene regions important for cell cycle control (15) 
and by silencing tumor suppressors and genes involved in DNA repair (16). This can lead 
to uncontrolled cell division, proliferation, and the loss of heterozygosity [reviewed in 
(17)]. 
Through the invention of whole genome sequencing a large number of mutations in 
the genes encoding for methyltransferases or other chromatin modifying proteins have 
been identified in tumor tissues (18, 19). This supports the assumption that the discussed 
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changes in DNA methylation and resulting changes in the transcriptional control of a cell 
can occur downstream of genetic abnormalities.  
1.1.2 Transcription factors 
Transcription factors are DNA binding proteins that recognize specific regulatory 
elements (promoters and enhancers) located cis- to target genes (20). By trans-acting with 
these motifs, transcription factors control the flow of genetic information from DNA to 
mRNA. Transcription factors are generally considered as final targets of signal-
transduction pathways, which include precise gene regulation in response to stress, 
hormones, or other stimuli (21). Abnormalities in transcriptional processes are implicated 
in a multitude of human diseases, including birth defects, cancer, endocrine disorders, and 
infertility. The fact that more than 5% of the entire genome encodes for transcriptional 
regulators underscores their biological importance (22, 23). (Transcription factors can be 
separated into various groups based on the structures of the DNA binding domain, 
including helix-turn-helix or zinc finger (20).  
1.1.3 GATA transcription factors 
The vertebrate GATA transcription factor family includes six members, named from 
GATA1 to GATA6 in the order of their discovery (24-29). GATA factors are zinc finger 
proteins that recognize a consensus DNA sequence, (A/T)GATA(A/G), known as the 
GATA motif (30). This motif serves as a cis-acting element in the promoters and 
enhancers of a variety of genes (31).  
tructurally GATA proteins consist of a basic domain with the nuclear localization 
sequence adjacent to the C-terminal zinc finger and two separate transcriptional activation 
domains close to the N-terminus (31-33). Whereas the C-terminal zinc finger is essential 
for DNA binding (32-34), the N-terminal directly interacts with other transcriptional 
regulators, such as Friend of GATA factors 1 and 2 (FOG1 and FOG2) (30). 
GATA factors, and especially their zinc finger domains, are evolutionary highly 
conserved throughout species and play major roles in the development and function of all 
eukaryotes (31) (Figure 2). Because of these similarities among the family members there 
exists redundancy in DNA binding properties to target sequences (34, 35). However, these 
in vitro properties contrast with their often non-redundant roles in vivo, which are 
determined in part by their tissue distribution and expression pattern [reviewed in (36)]. 
GATA factors can act as either activators or repressors of gene transcription depending on 
the context and their cooperative interaction with cofactors. The diversity in functionality 
is further accomplished through post-transcriptional modifications (36). 
REVIEW OF THE LITERATURE 
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Figure 2 Structure and homology of the GATA family. Numbers indicate the percentage of 
homology. The white areas represent the DNA-binding domain and the grey area indicates 
the nuclear localization sequence. Abbreviations: N, N-terminus; ZnF= zinc finger; C, C-
terminus. Modified from (36). 
GATA1, -2 and -3 are found in hematopoietic cells and involved in the regulation of 
erythroid and megakaryocyte precursor differentiation, the development of T 
lymphocytes, and the proliferation of hematopoietic stem cells (37, 38). It is also known 
that GATA2 and -3 are necessary for the development of the central nervous system (39). 
Null mutations in any of the hematopoietic GATA transcription factors lead to embryonic 
lethality (40-42).  
The second subgroup, which includes GATA4, -5 and -6, is mainly found in 
endoderm- and mesoderm-derived tissues, including the adrenal gland and gonads (33). 
Null mutations for these genes, except for Gata5, are embryonic lethal, emphasizing their 
pivotal role in early development (43-46). The expression patterns of GATA transcription 
factors and phenotypical features of germline deficient mice are listed in Table 1. 
Table 1  The GATA family  
 
This dissertation focuses on the first GATA family member discovered outside 
hematopoietic lineages, GATA4 (27).   
Expression profile*
* see text for references
Gata5 genitourinary tract, heart, primitive endoderm Viable; hypospadia in females
Gata6 gonads, adrenal gland, heart Lethal (E10.5); defects in gastrulation
Gata3
central nervous system, T 
lymphocytes, adenal gland, 
kindney
Lethal (E11); noradrenaline deficiency of the 
sympathetic nervous system
Gata4 gonads, fetal adrenal gland, heart, gut, intestine Lethal (E10.5); heart failure
Gata gene Phenotype of germline deficient mice*
Gata1 testis, hematopoietic cells Lethal (E10.5); defects in eythoid maturation
Gata2
hematopoietic and endothelial 
cells, central nervous system, 
primirdial germ cells
Lethal (E11.5); blockage of hematopoietic 
progenitor cell proliferation
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1.2 Development of the murine adrenal cortex and testis 
1.2.1 The common origin of adrenal glands and gonads  
The main steroidogenic organs, the adrenal glands and gonads, develop from a common 
pool of mesodermal progenitor cells within the urogenital ridge (47), which also gives rise 
to the kidneys (48-50) (Figure 3). Part of the coelomic epithelium develops into the 
adrenogenital primordium (AGP), which subsequently polarizes into two separate 
populations of cells, adrenal and gonadal primordia (47).  
 
Figure 3  From the urogenital ridge to mature steroidogenic tissues. The adrenal gland and gonads 
are the primary steroidogenic organs of mammals and arise from a common pool of 
mesodermal progenitor cells during embryogenesis. Abbreviations: E, embryonic day; dpp, 
days post partum; c, capsule; zG, zona glomerulosa; zF zona fasciculate; m, medulla; X, x-
zone. Modified from (51) and (47). 
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1.2.2 Development of the mouse adrenal gland 
At embryonic day (E) 10-10.5 the adrenogonadal primordium can be distinguished from 
the bipotential gonad due to the progressive separation of fetal cortical cells from the AGP 
(52). This separation is induced between E9.5 and E11 by contact with primordial germ 
cells (PGCs) and results in two distinct cell populations, the adrenal and gonadal 
primordial or anlage (53). Adrenal gland development continues with the encapsulation 
and colonization by neural crest cells, which migrate to the center and later give rise to the 
adrenal medulla (54). Smaller basophilic definitive cells, originating from the fetal adrenal 
cells of the AGP, will form the adult cortex. At E16 functional adrenocortical zonation is 
initiated and ends at week 3 post partum with three defined cortical zones: the zona 
glomerulosa (zG), zona fasciculata (zF), and X-zone. The latter zone regresses after the 
first pregnancy in females or in males at puberty (55, 56).  
The most prominent difference between human adrenal gland development, in 
contrast to mouse, is the appearance of an additional third cell layer, zona reticularis (zR), 
between zF and medulla around the age of four years (52).  
1.2.3 Testicular development in the mouse 
Gonadal development begins with the appearance of the bipotential gonad after PGC 
arrival at E10. Depending on the inheritance of an X or Y chromosome from the father at 
fertilization the bipotential gonad differentiates into either testis or ovary (48). At this 
stage of mouse embryonic development genital ridges of both genders have identical 
morphology. Between E10.5 and E12.5 male sexual differentiation is triggered by the 
expression of Sex-determining region of the Y chromosome (Sry) gene in pre-Sertoli cells 
of the developing testis (57). This genetic regulation determines if either the testis-specific 
pathway or the ovary-specific pathway is activated while the contrary pathway is 
continuously repressed. PGCs proliferate mitotically and differentiate into gonocytes 
(prespermatogonia), which are under mitotic arrest until birth (58, 59). Cells derived from 
the coelomic epithelium migrate into the undifferentiated gonad during E11 and then 
differentiate into Sertoli cells (SCs), which build testicular cords (49).  
After determination of male sex during E11-13 SCs enter a phase of proliferation and 
differentiation (60, 61). A series of coordinated gene expression events regulate distinct 
states of SC differentiation and function (62). For example, the initiation of SC 
differentiation during sex determination involves the DNA-binding proteins WT1, SF1, 
SRY, SOX9, GATA6, and DAX1 (48) (1.2.4). Based on its morphological appearance, the 
first distinction between a female and male embryo can be made after the initial testicular 
cord formation at E12.5 (63). At this time mesenchymal cells migrate into the genital 
ridge of the testis anlage and differentiate into testosterone producing Leydig cells (LCs) 
(64, 65). By E13.5 testicular differentiation is completed and at E17.5 testes and the 
internal genital duct system are identical to those in newborn. 
Testicular development is also in part determined by the production of hormones 
and hormone-like substances, such as testosterone and anti-Müllerian hormone (AMH, 
also known as Müllerian inhibiting substance, MIS) by the fetal testis. Those hormones 
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determine secondary characteristics, such as external genitalia and impair the production 
and maturation of germ cells and their absence results in a female phenotype (48). 
1.2.4 Genetic regulation of adrenal gland and testis development 
Proper gonadal and adrenal development are dependent on a genetic network build of 
transcription factors and signaling molecules. Developmental disorders, such as gonadal 
dysfunction, infertility or cancer are consequences of genetic network disturbance. 
Numerous factors contribute to the development of the adrenocortical and testicular 
structure and function. It is beyond the scope of this dissertation to discuss the plethora of 
modulators; however, Eggers et al., Val and Swain have reviewed those in detail (48, 66). 
The main genetic regulators involved in the development and homeostasis of the adrenal 
gland and testis are discussed below. Each of these factors is critical for proper cell 
differentiation and development. 
The Wilms’ tumor suppressor gene (WT1) is an important developmental factor for 
the formation of the bipotential primordium out of the urogenital ridge (67) and is 
expressed in the testis throughout fetal development (68). In the urogenital ridge of a 
mouse WT1 can be detected as early as E9.5. Using genetically engineered mice it was 
shown that Wt1 directly initiates the transcription of steroidogenic factor 1 (Sf1) (69). 
Another study demonstrated that Wt1, together with Cited2 (Cbp/p300-interacting 
transactivator, with Glu/Asp-rich carboxy-terminal domain, 2), regulates adrenal cortex 
differentiation (70). Although Wt1 plays an important role during early adrenal 
development, it is not expressed in the adult adrenal gland (71, 72). Loss-of-function 
mutations in Wt1 result in complete XY sex-reversal, presumably caused by 
downregulated SRY activity (73-75). Mutations in the WT1 gene have been connected to a 
variety of human diseases, including Frasier syndrome (73). 
Steroidogenic factor 1 (Sf1, Ad4BP, or Nr5a1) is another key transcription factor 
that directs cells to enter the ‘steroidogenic pathway’ and is required for the formation of 
gonads and adrenal gland (76, 77). It is expressed in the adrenal gland, gonads, 
hypothalamus, and pituitary gland (78). In mice, Sf1 is expressed in the urogenital ridge as 
early as E9 and is also present thereafter in gonadal and adrenal primordia of both sexes 
(79). SF1 is not essential for the formation of genital ridges, but it is required for the 
differentiation and maintenance of somatic testicular cells, including Leydig and Sertoli 
cells (50, 80). In the fetal testis it cooperates with WT1 and SOX9 (72, 81). SF1 regulates 
the expression of certain steroidogenic enzymes (82, 83). Mice lacking Sf1 are not able to 
develop adrenal glands and gonads and die shortly after birth (84, 85). In humans, 
heterozygous SF1 gene mutations cause adrenal failure and XY sex reversal (86, 87). 
Dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome 
X, gene 1 (Dax1) is a nuclear hormone receptor which, like Sf1, is expressed in the adrenal 
cortex, gonads, hypothalamus, and pituitary gland (88). It is expressed in the gonads of 
both sexes (88) and is, along with WNT4, considered to be an anti-testis gene and 
proposed to act as an SRY antagonist (89). During different stages of steroidogenesis 
DAX1 acts as a repressor, suppressing the same genes activated by SF1, including 
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steroidogenic acute regulatory protein (StAR) and certain steroidogenic enzymes (90-92). 
DAX1 deficient mice show impaired X-zone degeneration and resemble the human 
phenotype of adrenocortical failure (89). In humans, gene mutations in DAX1 lead to 
developmental defects, including X-linked adrenal hypoplasia congenita and 
hypogonadotrophic hypogonadism (93, 94). 
Sex-determining region of the Y chromosome (Sry), a Sox (Sry-related HMG box) 
gene family member is expressed in the genital ridge of both sexes at E10.5. While SF1 
and WT1 play a main role during establishment of the urogenital ridge, SRY triggers testis 
development from the indifferent urogenital ridge (48). Loss of SRY function results in 
the development of XY females (95) and female mice harboring a SRY gene develop into 
a males (96). In humans, point mutations in the SRY gene result in XY gonadal 
dysgenesis (97). 
SRY (sex determining region Y)-box 9 (Sox9), is a downstream target of SRY and 
expressed in the testes of all vertebrates (98). During XY embryonic development Sry 
expression peaks at E11.5 and consequently Sox9 gene transcription is highly active (99, 
100). High expression levels of Sox9 in those SRY positive cells lead to their 
differentiation into SCs (101, 102). SOX9 regulates the expression of AMH and SF1 (81). 
Conditional deletion of Sox9 in the gonads of XY mice results in the development of 
ovaries (103). In turn, overexpression of Sox9 in XX embryonic gonads leads to testis 
formation (104, 105). SOX9 regulates AMH expression through interactions with other 
transcription factors, including WT1, SF1 and GATA4 (72, 106-109). AMH is not 
required for testis development but it is essential for the regression of the uterus and the 
upper part of the vergina (110). In humans, point mutations in the SOX9 gene cause XY 
gonadal dysgenesis, such as autosomal sex reversal (97, 111). 
Two members of the GATA transcription factor family, GATA4 and GATA6 are 
known to affect the balance between adrenal and gonadal differentiation (112). Gata4 is 
expressed early during development and gene deletion using the Cre-LoxP system in the 
whole embryo at E8.75 disturbs proper development of the genital ridge and the ability of 
PGC to become gametogenesis-competent (113, 114). On certain genetic backgrounds, 
mice harboring a heterozygous Gata4 gene mutation exhibit male-to-female sex reversal 
(115). During testicular differentiation GATA4 is a positive regulator of Sry expression 
(116), necessary for testis cord formation and the expression of Doublesex and mab-3 
related transcription factor 1 (Dmrt1), a transcriptional regulator required for postnatal 
testis differentiation (117). Further, GATA4 regulates the transcription of steroidogenic 
markers [StAR, Cyp19a1 (cytochrome P450, family 19, subfamily a, polypeptide 1)], 
hormones (AMH, inhibins and activins) and transcription factor Sf1 (109, 118-125). Loss-
of-function mutation in the human GATA4 gene causes an azoospermic phenotype (126). 
Gata6 is coexpressed with Gata4 during fetal mouse development and found in 
adrenocortical cells and somatic testicular cells (SCs and LCs) (29, 119, 127, 128). After 
birth, Gata4 expression in the adrenal cortex disappears, but in turn Gata6 expression 
persists in both, adrenal cortex and testis (36, 129, 130). Conditional mutagenesis of 
Gata6 in mice causes defects in adrenal cortical function (131). The expression of this 
transcription factor is reported to be downregulated in carcinomas of the human adrenal 
gland (132).  
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1.3 Hormonal regulation of steroidogenesis in the adrenal cortex 
and testis 
1.3.1 Hypothalamic-pituitary-adrenal/gonadal axis 
The production of steroids is one of the main functions of the adult adrenal cortex and 
gonads. Hormones secreted from the pituitary gland are important regulators of adrenal 
and gonadal function (Figure 4).  
 
Figure 4 Hypothalamic-pituitary-adrenal/gonadal axis. Hormone secretion and regulatory pathways 
within the hypothalamic-pituitary-adrenal/gonadal axis are illustrated. Solid lines indicate 
stimulatory (+), and dotted lines inhibitory (-) effects. Abbreviations: CRH, corticotrophin 
releasing hormone; GnRH, gonadotropin releasing hormone; ACTH, adrenocorticotropin; 
LH, luteinizing hormone; FSH, follicle stimulating hormone. Modified from (133). 
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Adrenocorticotropin (ACTH), a hormone produced by the pituitary, regulates fetal 
adrenocortical steroidogenic activity and controls the secretion of cortisol and androgens 
in the adult. ACTH is under the regulation of hypothalamic corticotropin-releasing 
hormone (CRH) and controlled by a negative feedback loop of adrenocortical 
corticosteroids. The secretion of the main gonadotropins regulating testicular functions, 
follicle stimulating hormone (FSH) and luteinizing hormone (LH), is controlled by 
hypothalamic gonadotropin-releasing hormone (GnRH) (134). FSH targets SCs, whereas 
LH targets LCs. Gonadotropins have no influence on the fetal development of those cells. 
However, during postnatal period, gonadotropins stimulate the proliferation of SCs and 
play also an important role in respect of differentiation and proliferation of adult LCs 
(135-137).  
In response to LH stimulation LCs produce testosterone that is essential for 
spermatogenesis (138, 139). Luteinizing hormone chorionic gonadotropin receptor 
(LHCGR, or LH receptor) located on the cell surface of these gonadal steroidogenic cells 
interacts with the LH protein and transmits effects, including cell growth, differentiation 
and steroid production by activation of transcription factors which initiate the expression 
of genes encoding for steroidogenic enzymes (140). The activation of transcription factors 
occurs through various signaling pathways, including the cAMP/protein kinase A (PKA) 
pathway, the mitogen-activated protein (MAP) kinase pathway and the 
phosphatidylinositol-3-kinase pathway (140, 141). For the detailed hormonal function of 
FSH on SCs and spermatogenesis  see 1.5.2. 
The main endocrine negative feedback regulators of gonadotropin secretion are 
testosterone and inhibin (142, 143). Inhibin, a heterodimer of α- and β-chains, serves also 
as a marker for spermatogenesis and SC function (144). Activin, a homo- or heterodimer 
of β-chains produced by SCs, serves as a paracrine or autocrine regulator within the 
pituitary and testis, as it enhances FSH secretion and locally modulates androgen 
production, influencing proliferation of SCs and germ cells (145, 146). 
1.3.2 Steroidogenesis in the adrenal cortex and testis 
ACTH and LH secreted by the pituitary gland regulate the uptake and homeostasis of 
cholesterol in the adrenal gland and testicular LCs (147). In response to endocrine and 
paracrine signals steroids are synthesized from cholesterol through its sequential 
conversion by a series of cytochrome P450 (CYP) enzymes and hydroxysteroid 
dehydrogenases (HSDs) (148) (Figure 5).  
Anatomically and functionally distinct zones in the adrenal cortex synthesize 
specific steroid hormones: mineralocorticoids are produced by cells of the zG, 
glucocorticoids are secreted by zF cells, and adrenal androgens [dehydroepiandrosterone 
(DHEA)] secreted by cells of the zR (149).  
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Testicular LCs are the primary source of androgens and secrete sex steroids, mainly 
testosterone (148). In mammals, two distinct populations of LCs, fetal and adult LCs, 
develop sequentially (150). Fetal LCs do not express Hsd17b3 and adjacent, fetal SCs are 
necessary to convert androstenedione to testosterone. In contrast, adult LCs synthesize 
testosterone by themselves.  
 
Figure 5  Steroidogenic pathways in the human adrenal cortex and Leydig cells of the testis. Both 
organs share the same enzymes during the first steps of steroidogenesis. The presence of 
specific enzymes in a distinctive cell type, however, defines differences in steroid hormone 
production among steroidogenic tissues. Modified from (51). 
 
In contrast to humans, the adult mouse adrenal gland lacks cytochrome P450 17α –
hydroxylase/17,20-lyase (P450c17 or CYP17A1) (151). As a consequence no androgens 
are produced and the main secreted glucocorticoid is corticosterone instead of cortisol.  
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1.4 The adult adrenal cortex 
1.4.1 Structure  
The adrenal glands are a pair of small ovoid structures situated one on either side of the 
midline near the anterior pole of the kidney and are one of the main endocrine organs. In 
the mouse, the adrenal medulla is surrounded by the adrenal cortex which consists of three 
distinct cell layers, named zG, zF and X-zone (54). The latter layer disappears during 
puberty in males and the first pregnancy in females (148). The zG secretes 
mineralocorticoids, whereas zF mainly produces glucocorticoids (Figure 5) (149). 
The mouse adrenal cortex undergoes continuous renewal throughout adult life (152). 
Multipotential stem/progenitor cells reside in the subcapsular region and give rise to 
daughter cells, which are able to differentiate into cells of each functional zone of the 
adrenal cortex (153, 154). During this constant turnover the majority of stem and 
progenitor cells proliferate in the adrenal gland periphery, i.e. in the outer cell layers of zF, 
and then move centripetally (54, 154).  
1.4.2 GATA factors in the adult adrenal cortex 
Homeostasis of the adrenal cortex is tightly regulated, and GATA6 has been identified to 
be a key factor during this process (131). GATA6, the principal GATA factor in the 
adrenal gland, is expressed in the capsule and subcapsular cells of the adult mouse (131). 
As recently reviewed GATA6 enhances the in vitro expression of several key players of 
adrenocortical steroid biosynthesis, including Cyp11a1, Cyp17a1, and Hsd3b2 (112). 
Mice with germline null mutations in both alleles of the Gata6 gene die early during 
embryonic development hampering the usage of this model to study the in vivo roles of 
GATA6 in adrenocortical cells (45). Consequently the loss of GATA6 in the adrenal 
cortex was studied after gene deletion using Sf1-Cre (131) and revealed a pleiotropic 
phenotype (Figure 6): a thin and cytomegalic adrenal cortex, downregulated expression of 
Cyp11b2, diminished glucocorticoid synthesis, subcapsular cell hyperplasia coupled with 
upregulation of gonadal-like markers, ectopic chromaffin cells, and the lack of X-zone 
(131). Based on these results GATA6 is thought to control adrenal cortex homeostasis by 
regulating stem/progenitor cell differentiation.  
Due to its restricted expression pattern during development and absence in the adult 
adrenal cortex, GATA4 was believed to play a more limited role in the function of this 
endocrine organ (129). And indeed, in contrast to Gata6 conditional knockout (cKO) 
mice, the targeted ablation of Gata4 is not associated with an adrenal phenotype (Figure 
6) (117).  
Interestingly, however, the phenotype of double mutants, lacking both GATA4 and 
GATA6, differs from the phenotype of mice lacking only GATA6 (155, 156). Whereas 
females die shortly after birth due to adrenocortical insufficiency, male pups survive. 
Males survive owing to ectopic corticoid production by adrenocortical-like cells in the 
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testis. The drastic adrenocortical phenotype of double-mutant mice, which show 
adrenocortical aplasia, indicates a synergistical function of these transcription factors. The 
investigators summarize that GATA6 acts as the general driver of adrenocortical 
homeostasis and compensates for GATA4 loss (156). However, GATA4 fulfills essential 
regulatory functions in GATA6 deficient mice and helps to sustain adrenocortical 
steroidogenic cells and thus guarantees the survival of females. Figure 6 summarizes the 
adrenocortical phenotypes of discussed GATA deficiencies and corresponding gonadal 
phenotypes are shown in Figure 10. 
 
Figure 6 Adrenocortical phenotypes of Gata4 and Gata6 single and double cKO mice generated 
with the LoxP system using Sf1-Cre. Adult Gata6 cKO mice show a thin cytomegalic 
cortex, the accumulation of subcapsular gonadal-like cells, ectopic medulla cells, and lack 
the X-zone (131). The adrenal glands of adult Gata4 cKO mice exhibit no phenotypic 
abnormalities (117). Mice deficient for GATA4 and GATA6 reveal adrenocortical aplasia at 
birth. Only males survive as nests of adrenal-like cells accumulate in the testis and produce 
ectopic corticoids compensating for adrenocortical insufficiency in those mice (156). 
Modified from (157). 
1.4.3 Adrenocortical tumors 
Incidentalomas represent the most common form of human adrenocortical tumors (ACT). 
Those tumors are found incidentally during abdominal radiologic examination in about 
7% of patients older than 70 years (158, 159). Hormonally inactive incidentalomas are 
typically benign adrenocortical adenomas that do not require any form of treatment. A 
subset of incidentalomas are hormonally active, secreting aldosterone or cortisol (160). 
The rarest type of ACT is malignant adrenocortical carcinoma (ACC) (1 case per million 
per year). These aggressive malignancies have a propensity to metastasize and are 
associated with a poor prognosis (5-year survival rate of <40%) (161). Certain genetic 
disorders, such as Beckwith-Wiedemann syndrome and Li-Fraumeni syndrome, are 
associated with an increased risk of ACC in childhood [reviewed in (162)]. 
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1.4.3.1 Molecular pathogenesis of adrenocortical tumors 
A few key signaling pathways have been implicated with the molecular pathogenesis of 
ACT. Cortisol-secreting adenomas have been linked to somatic mutations in genes 
controlling the cAMP/PKA signaling pathway, mainly the PKA (protein kinase A) 
catalytic subunit α (163). Somatic genetic alterations in ACCs often enhance Wnt/β-
catenin signaling. Activating mutations in CTNNB1, the gene encoding for β-catenin, are 
common in ACCs (164), as are loss-of-function mutations in ZNRF3 (zinc and ring finger 
3) and KREMEN1 (kringle containing transmembrane protein 1), two inhibitors of Wnt 
signaling (163). A variety of syndromes and gene mutations, that cause the loss or gain of 
chromosomes, have been identified and are associated with adrenocortical neoplasia (160, 
161, 165). In the mouse, interrupting β-catenin signaling resulted in decreased tumor 
formation, decreased ACC cell proliferation and increased apoptotic activity (166). A 
series of investigations discovered abnormal mRNA expression levels for a variety of 
other genes: growth factor IGF2, TGF-β signaling factor Inhibin-α (INHA), and a tumor 
suppressor (TP53) (167-169).  
Of interest, there is emerging evidence that GATA transcription factors play a direct 
role in the initiation, proliferation, and propagation of endocrine tumors, including 
adrenocortical neoplasms. When compared to normal adrenal cortex and adenomas, 
transcription factor GATA6 is downregulated in human ACC (132) and the diminished 
expression of GATA6, SF1, and their target gene INHA is related to poor outcome (170). 
In turn, GATA4, which is normally not expressed in the adult adrenal cortex, is extensively 
expressed in ACCs and adenomas (171).  
1.4.3.2 Gonadectomy-induced adrenocortical neoplasia  
The development of adrenocortical neoplasms in the subcapsular region of the adrenal 
gland has been reported in postmenopausal women and patients with testicular atrophy 
(172, 173). These neoplasms histologically resemble ovarian tissue, and it is hypothesized 
that elevated LH levels and a decline in sex steroids trigger tumorigenesis (153). Certain 
mouse strains respond in the same manner to gonadectomy (GDX) and develop sex 
steroid-producing gonadal-like neoplasms. Susceptible inbred strains include DBA/2J and 
C57B1/6 x DBA2/J F1 (B6D2F1) [reviewed in (153)]. 
Elevated LH and LHCGR levels, and the ectopic expression of this receptor trigger 
the formation of neoplasms in the mouse adrenal cortex (174, 175). In response to a surge 
of GnRH the hormone LH is secreted in a pulsatile manner from the pituitary gland and 
stimulates sex steroid production in the testis (see Figure 4). Under basal conditions, the 
secreted sex steroids inhibit GnRH production using a negative feedback loop. However, 
after GDX the negative feedback is absent and levels of LH and other gonadotropins are 
continuously elevated.  
In the early stages of GDX-induced adrenocortical neoplasia densely grouped small 
cells appear below the capsule (176). These are non-steroidogenic, basophilic type A cells 
which become spindle-shaped, extend within the zG, and later invade all zones of the 
adrenal cortex (177). Later, nests of large, lipid-laden type B cells appear (176, 178). Type 
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B cells presumably arise from type A cells and express typical markers of gonadal 
steroidogenic cells, including Gata4, Lhcgr, Inha, and enzymes required for sex steroid 
biosynthesis (Cyp17a1, Hsd17b3, Cyp19a1) (153, 179). In turn, adrenocortical markers, 
such as Gata6 and genes encoding for adrenocorticoid biosynthetic enzymes, including 
Cyp21a1, Cyp11b1, and Cyp11b2 are downregulated in GDX-induced neoplasms (153, 
180). Steroid hormone biosynthesis in normal (dashed lines) and neoplastic (solid lines) 
adrenocortical cells of the mouse is shown in Figure 7. 
 
 
Figure 7 Altered steroid hormone biosynthesis in GDX-induced neoplastic cells of the adrenal 
cortex. The presence and expression of enzymes determine the steroidogenic capacity of 
normal (dashed lines) versus neoplastic (solid lines) adrenocortical cells of the mouse. 
Modified from (153). 
Fate mapping experiments have shown that progenitor cells located in the adrenal 
capsule express markers of the AGP (GATA4 and WT1), suggesting GATA4-expressing 
neoplastic cells arise from this distinctive pool (128). Under basal conditions these 
progenitor cells differentiate into normal steroidogenic cells, but GDX directs their 
differentiation into gonadal-like cells. Experiments in this dissertation address whether 
GATA4 is a direct regulator of adrenocortical neoplastic tumor formation or if this 
transcription factor is merely a marker for this event.  
1.4.3.3 DNA methylation changes in GDX-induced adrenocortical neoplasia 
Not only genetic factors, but also epigenetic modifications, such as DNA methylation, are 
thought to play a role in the pathogenesis of GDX-induced adrenocortical neoplasia. It has 
been shown that stem/progenitor cells in the mouse adrenal cortex show epigenetic 
variability (181, 182). Those epigenetic modifications are thought to affect the phenotypic 
plasticity of adrenocortical stem/progenitor cells, that in turn allows these cells to respond 
to hormonal changes following GDX (183). Studies in this dissertation characterize the 
changes in DNA methylation associated with GDX-induced adrenocortical neoplasia in 
the mouse. 
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1.5 The adult testis 
1.5.1 Postnatal development and structure 
After birth the testis is still immature and postnatal development leads to a functionally 
mature organ, capable of producing spermatozoa and testosterone.  
During postnatal development the number of SCs increases dramatically and 
proliferation is at its peak during puberty in mice (184). SCs are one of the key structural 
components of the seminiferous tubule and provide the cytoarchitectural support for the 
developing germ cells. Right after birth gonocytes start to differentiate into spermatogonia 
and at puberty they begin to develop further into mature spermatozoa, a process known as 
spermatogenesis (59). In contrast to SCs, the number of LCs stays rather constant 
throughout infancy. During puberty those cells differentiate into mature testosterone 
producing cells (185). 
The adult testis is composed of seminiferous tubules and interstitial tissue and 
contains four cell populations or lineages: germ cells, connective tissue cells, steroid 
producing cells, and supporting cell types such as Sertoli- and myoid cells (Figure 8). LCs 
are located together with other somatic cells, including macrophages and vascular 
endothelial cells, in the interstitial space of the seminiferous tubule (186). Peritubular 
myoid cells are mesenchymal derived and separated from SCs by a basement membrane, 
the basal lamina. The germ cell types within a seminiferous tubule are spermatogonia, 
spermatocytes, spermatides and mature spermatozoa. The development of germ cells 
within the seminiferous tubules is predominantly supported and controlled by SCs. This is 
true for both the structural and the nutritional basis. Therefore, one of the most critical 
matters influencing spermatogenesis, testis function and male fertility is the regulation of 
SC function.  
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Figure 8 Adult testis physiology and spermatogenesis of the mouse. Illustrated on the left is a cross 
section of the testis. Testosterone producing Leydig cells are located in the interstitial space 
between seminiferous tubules that harbor Sertoli cells and developing germ cells. Within the 
seminiferous tubule spermatogenesis takes place. During spermatogenesis developing germ 
cells are in close contact to Sertoli cells, via special adherens junctions exclusively found in 
the testis (ES; ectoplasmic specializations), and have to overcome the BTB. Depending on 
the localization of the ES we distinguish between apical and basal ES. Spermatogenesis 
involves mitotic and meiotic divisions of germ cells and gives rise to haploid spermatids that 
develop further during spermiogenesis. Mature spermatozoa are located in the lumen of the 
tubule and released during spermiation. ES, ectoplasmic specializations; BTB, blood-testis 
barrier. Modified from (157) and (187). 
1.5.2 Sertoli cell function and spermatogenesis 
In the adult, SCs function to promote and maintain spermatogenesis through: 1) the 
provision of structural support for developing germ cells; 2) the formation of the BTB to 
create a unique microenvironment for developing germ cells; 3) the transmission of 
hormonal and environmental signals to developing germ cells through paracrine signaling 
pathways; and 4) the supply of nutrients as energy source for developing germ cells [for 
review (188-193)].  
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1.5.2.1 Spermatogenesis  
Spermatogenesis is a precisely regulated process by which cellular division and 
transformation of male diploid (2n) spermatogonial stem cells produce haploid (1n) 
mature spermatozoa within the seminiferous tubules of the testis (194). SCs adhere to the 
basement membrane, surround meiotic and postmeiotic developing germ cells and provide 
a unique microenvironment for the development and maturation of these cells. 
During fetal germ cell development, primordial germ cells differentiate into 
gonocytes, which directly after birth differentiate into spermatogonia (59). With the onset 
of puberty spermatogonia start to proliferate (stem cell renewal) or enter spermatogenesis 
by following the germ cell differentiation pathway and consequently develop into mature 
spermatozoa. During spermatogenesis type A spermatogonia undergo mitosis resulting in 
type B spermatogonia, which then enter a meiotic prophase and differentiate into primary 
spermatocytes (194). As spermatocytes undergo meiosis I, the separation of the 
homologous pair of chromosomes takes place and yields two haploid secondary 
spermatocytes. Those in turn undergo meiosis II and give rise to four spermatids that 
migrate towards the lumen of the seminiferous tubule.  
The final step in germ cell development is called spermiogenesis and describes the 
morphogenesis of spermatids into mature, motile spermatozoa [reviewed in (195)]. 
Morphologically spermiogenesis of the mouse can be divided into 16 steps: development 
of acrosomes and flagella (step 1-7), orientation of the spermatid head towards the basal 
compartment (step 8), condensation of the nucleus and elongation of the flagella (step 9-
13), alignment of mitochondria along the flagella (step 14 and 15), and adluminal 
translocation (step 16). After spermiogenesis is completed fully developed spermatozoa 
leave the seminiferous tubule via spermiation.  
Histological cross sections of the seminiferous tubules revealed recurring germ cells 
in distinct states of differentiation that are always found together (195). This discovery 
was named spermatogenic cycle and in the mouse it describes 12 histological 
distinguishable stages and takes 8-9 days to complete. However, for a single 
spermatogonium it takes about 35 days to complete spermatogenesis because developing 
germ cells go through the cycle 4.5 times before being released to the lumen of the 
seminiferous tubule. Indicating the importance of SC during these extensive cell 
movements across the epithelium, morphometric analysis of adult rat testis revealed that 
each SC interacts with 30-50 germ cells at each stage of the spermatogenic cycle (196). 
Throughout spermatogenesis developing germ cells remain attached to the SC 
epithelium. The close contact between SCs and developing germ cells is sustained via cell-
cell anchoring junctions (mainly adherens junctions) and their attachment sites of actin 
filaments that are specific to the testis, and known as ectoplasmic specializations (ES) 
(197, 198). Within the seminiferous epithelium there are two ESs that are classified 
according to their localization (198). The basal ES is located at the BTB and found near 
the basement membrane and together with junctional complexes responsible for cell 
adhesion (199). The other ES is found between SCs and spermatids in the apical 
compartment of the seminiferous tubule and thus named apical ES (200).  
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1.5.2.2 Blood-testis barrier  
The BTB is one of the tightest blood-tissue barriers composed of tight junctions (TJs), 
basal ES [testis specific adherens junctions (AJs)], gap junctions (GJs), and desmosomes 
(DS) that link two adjacent SCs with each other (197, 201). All of those adhesion 
junctions are connected to the actin cytoskeleton, except DS, that uses vimentin-based 
intermediate filaments as anchor (202). 
The BTB creates a unique microenvironment essential for spermatogenesis and 
separates the seminiferous epithelium into two distinct milieus: 1) the basal compartment 
that harbors spermatogonial stem cells (SSCs), and 2) the apical compartment that is 
isolated from the systemic circulation through the BTB and contains meiotic and post-
meiotic germ cells (201). The barrier controls the passage of molecules into the adluminal 
compartment of the seminiferous tubule and back, confers cell polarity and functions as an 
immunological barrier (203). By segregating post-meiotic germ cells from the systemic 
blood stream autoimmune responses against specific antigens of those cells is prevented. 
During spermatogenesis spermatocytes migrate progressively from the basal to the 
apical compartment and thus traverse the BTB at stage VIII of the murine epithelial cycle. 
To permit the passage of differentiating germ cells the BTB undergoes remodeling and 
without this timely germ cell movement spermatogenesis cannot be completed, resulting 
in infertility (197, 204). Traversing the BTB requires the assembly of a ‘new’ BTB behind 
the transiting spermatocyte and the timely coordinated disassembly of the ‘old’ BTB at the 
other side of the spermatocyte (205). To accomplish those junctional dynamics during 
spermatogenesis and to maintain the functional integrity of the barrier cytokines such as 
tumor necrosis factor (TNF) and transforming growth factor-beta3 (TGF-beta3) regulate 
SC specific cell-cell interactions by determining the homeostasis of TJ- and basal ES-
structural proteins, proteases, protease inhibitors, and other extracellular matrix (ECM) 
proteins (e.g., collagen) (206-209). 
1.5.2.3 Adhesion molecules and regulating factors at the BTB and apical ES  
Adhesion molecules and regulating factors found at the BTB and apical ES are highlighted 
below. In addition, the interested reader is encouraged to reflect the work of Lui, Cheng, 
Siu and Mruk that provides an excellent overview about testicular cell junctions, their 
dynamics and identified component proteins (197, 206, 210). 
The claudin (CLN) family counts as of today 24 members and those intercellular 
adhesion molecules are the main constituents of the TJs in mammals (211). Claudins show 
a distinct organ-specific expression profile and Cldn11 has been identified to be 
responsible for the formation of TJ between SCs (212-214). Adult mice deficient for 
Cldn11 in SCs exhibit a dysfunctional BTB and increased apoptotic germ cell number 
(215). The cell polarity of SCs and contact to the basement membrane in Cldn11 knockout 
mice is lost, which results in infertility (216). 
Occludin (OCLN), another key component of TJs in the BTB, exhibits a stage 
specific expression profile during the spermatogenic cycle and during stage VIII, when 
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germ cells migrate through the BTB, it is not detectable by immunostaining (217-219). 
Mice deficient for Ocln develop age-dependent atrophy of seminiferous tubules that are 
devoid of germ cells (220). 
Members of zonula occludens (ZO) protein family are adaptor proteins that tether 
integral membrane proteins, such as CLN and OCLN to the actin cytoskeleton (221, 222). 
ZO-1, also known as TJ protein 1 (TJP1) is found at the inter-SC junctions of the mouse 
(223). Mice deficient for TJP1 show embryonic lethality that is connected to the 
disruption of the paracellular barrier and cellular junctions (224). Further, it was reported 
that depletion of TJP1in a mammary epithelial cell line completely abrogates TJ assembly 
(225), and BTB disruption in testicular carcinoma correlates with decreased expression of 
TJP1 (226). 
Connexins (CX) are transmembrane proteins that assemble to form gap junctions 
and family member 43 is the predominant testicular GJ protein found between adjacent 
SCs and between SCs and germ cells (227). Its location resembles the ones of Ocln, ZO-1 
and N-cadherin (228). Mice harboring SCs deficient for Cx43 are infertile and show 
testicular atrophy connected with failures in spermatogenesis (229). 
Type IV collagen and laminins are ECM elements and the main structural 
components forming the basement membrane within the testis (230, 231). Collagen α1(IV) 
and α2(IV) chains are produced by SCs and myoid cells, whereas α3(IV) chains are 
products of SCs and germ cells (207). The involvement of collagen α3(IV) in the 
dynamics of TJs was proven by investigations that associated the assembly of SC TJs in 
vitro with increased collagen α3(IV). Further supporting the hypothesis that ECM 
components affect TJ dynamics was the treatment of SCs with an anti-collagen antibody 
what resulted in a reversibly disruption of the barrier formation. Although detailed 
molecular mechanisms are not known it is proven that, at least in part, cytokines, such as 
TNF regulate the homeostasis of the ECM through proteolysis (207).  
Laminins, together with integrins, provide adhesion between epithelial cells and the 
basal lamina. They are heterodimers and composed of α, β, and γ chains. In mammals 5 α 
subunits, 4 β-subunits and 3 γ-subunits are identified which give rise to 16 different 
functional laminins (232). Laminin γ3 (LAMC3) is found at the apical ES and is reported 
to build a complex with integrin (233). The antibody-induced blockage of laminin-333 
(composed of laminin α3-, β3-, and 3γ- chains) located at the apical ES was shown to 
perturb adhesion between SCs and germ cells, resulting in germ cell loss from the 
epithelium (234).  
Tumor necrosis factor (TNF), a cytokine, mainly produced by activated monocytes 
and macrophages in the circulation is well associated with inflammation, cell proliferation 
and apoptosis (235). In the testis it is locally produced by germ cells, macrophages, and 
SCs, and reported to regulate LC steroidogenesis and germ cell apoptosis (207, 236, 237). 
The spontaneous degeneration of rat germ cells is reduced in the presence of TNF, 
illustrating its germ cell survival effect (236, 238). Further, TNF was found to alter actin 
organizations in SC cultures in vitro (239). Its regulatory importance on BTB dynamics 
was demonstrated in an experiment where recombinant TNF disturbed BTB permeability 
in a dose-dependent manner and resealing of the barrier occurred upon its removal (207). 
This effect of BTB restructuring was also demonstrated in vivo (208). The observation that 
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TNF expression levels peak at stage VIII, when spermatocytes migrate across the BTB, 
supports the hypothesis that this cytokine contributes to BTB opening during germ cell 
development (207). Importantly, TNF was also shown to determine steady-state protein 
levels of the integral membrane protein OCLN and thus regulating TJ permeability both, 
in vivo and in vitro (207, 208). Additional studies revealed that the presence of TNF 
induces SC collagen α3(IV), matrix metalloprotease (MMP)9 and the tissue inhibitor of 
metalloproteases (TIMP)1. MMPs and TIMPs are involved in ECM remodeling and 
function in a synergistical manner (240). In summary, these results foster the assumption 
that MMPs are activated via TNF and break down collagen. These cleavage processes 
affect the scaffolding function of ECM and consequently disrupt TJ formation because 
SCs can no longer attach to an intact ECM (240).  
Several transcription factors, including Smad proteins, CREB (cAMP responsive 
element binding protein 1), SP1 (trans-acting transcription factor 1), and KLF4 (Kruppel-
like factor 4) have been identified to play a critical role in the transcriptional regulation of 
cell adhesion proteins at the BTB (241-245). However, the knowledge that the conditional 
deletion of Gata4 disrupts BTB integrity in vivo supports the hypothesis that this list of 
transcriptional regulators, controlling cell adhesion proteins at the BTB, is incomplete 
(117, 246, 247).  
1.5.2.4 Sertoli cell metabolism and lactate production  
In addition to providing a structural framework for spermatogenesis, SCs provide trophic 
support for developing germ cells. Among the molecules secreted by SCs are growth 
factors and chemokines that promote SSC self-renewal and maintenance [reviewed in 
(248, 249)]. Additionally, the flow of essential nutrients to germ cells in the apical 
compartment is regulated by SCs (192). Spermatogonia use mainly glucose as an energy 
source for ATP production. More developed germ cells, such as spermatids, located in the 
apical compartment and thus separated from the systemic circulation, rely on exogenous 
SC-derived lactate as fuel (191, 250). Round spermatids favor lactate as substrate and 
energy production is more efficient when this metabolite is present in high concentrations 
(250-252). The importance of lactate as a fuel source is further supported by reports 
showing that spermatogenesis in adult cryptorchid testis is improved following lactate 
infusion (253) and that lactate has an antiapoptotic effect on germ cells (254). Taken 
together, adequate lactate production by SCs appears necessary for germ cell survival, 
spermatogenesis, and male fertility [reviewed in (190)]. 
To guarantee sufficient lactate production levels SCs show metabolic features 
typical of cancer cells. The so-called Warburg phenotype, describes a metabolic profile in 
which the majority of pyruvate generated via glycolysis is converted to lactate instead of 
being oxidized by entering the tricarboxylic acid (TCA) cycle (192, 255). Instead of using 
glucose for their own energy needs, SCs rely on the β-oxidation of lipids recycled and 
derived from apoptotic spermatids that were phagocytized and degraded (256). This idea 
is supported by the phenomenon than SCs sustain their viability in the absence of glucose 
and inhibiting glycolysis in this cell type does not influence ATP production (190, 256).  
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Another mechanism by which SCs maximize lactate production is through the use of 
alternative fuels. For example the oxidation of glutamine via glutaminolysis has been 
reported to yield much of the energy required for lactate production and support of 
spermatogenesis (257). Not only glutamine, but also other amino acids such as alanine, 
leucine, and valine, have been reported to be metabolized in anabolic pathways by SCs, 
facilitating lactate production (258). Figure 9 illustrates the typical metabolic profile seen 
in SCs that favors lactate production. 
 
 
 
Figure 9  Metabolic profile of Sertoli cells. The three major steps in shunting glucose to lactate 
within SCs are regulated by 1) glycolytic enzymes (converting glucose to pyruvate), 2) PDC 
(regulating the entry of pyruvate into the TCA cycle), and 3) LDH (converting pyruvate to 
lactate). Additionally, SCs use glutamine via glutaminolysis for lactate production. Lactate 
is secreted for the nutritional support of developing germ cells. Abbreviations; Hk1, 
hexokinase 1; Gpi1, glucose phosphate isomerase 1; Pfkp, phosphofructokinase, platelet; 
Pgam1, phosphoglycerate mutase 1; LDH, lactate dehydrogenase; PDC, pyruvate 
dehydrogenase complex; Pdk3, pyruvate dehydrogenase kinase, isoenzyme 3; Pdk4, 
pyruvate dehydrogenase kinase, isoenzyme 4; Gls2, glutaminase 2; TCA Cycle, 
tricarboxylic acid cycle; SC, Sertoli cell. Modified from (192). 
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1.5.2.5 Hormonal control of Sertoli cell function  
Other key players in the regulation of SC function are the gonadotropins, FSH and LH 
(see Figure 4) (199). 
FSH secreted from the pituitary gland, increases the activity of lactate 
dehydrogenase (LDH) in SCs and consequently enhances lactate production by limiting 
the entry of pyruvate into the TCA cycle (133, 259, 260). FSH acts by binding to G 
protein-coupled receptors that are exclusively located on SCs (138) and determines adult 
spermatogenic capacity by controlling SC proliferation during puberty. In adult SC 
function FSH exerts metabolic control through increasing phosphorylated protein kinase B 
(p-PKB) levels in a phosphatidylinositol 3-kinase (PI3K)-dependent manner (261). SCs 
treated with a PI3K inhibitor suffer from a partial blockage of lactate biosynthesis and 
decreased LDH activity, suggesting that FSH serves as a key modulator of lactate 
production in those cells (261). It has been shown that the presence of FSH is not an 
absolute requirement to maintain spermatogenesis (143), however the presence of 
testosterone seems to be essential for male fertility (262).  
The major testicular androgen, testosterone, is secreted by LCs in response to LH 
stimulation and diffuses into the seminiferous tubules. Its effects are mediated via the 
androgen receptor (AR), present in SCs (263) but not in germ cells (264). During 
spermatogenesis at least four critical processes are testosterone dependent [reviewed in 
(265)]: 1) BTB maintenance, 2) meiosis of developing germ cells, 3) adhesion of 
spermatids to SCs, and 4) spermatozoa release.  
Functionally important tight junction proteins of the BTB (occludin and claudins) 
are decreased in the absence of AR, indicating that testosterone is required for BTB 
dynamics (266). Furthermore, testosterone acts to maintain barrier remodeling by 
facilitating the reassembly of proteins on the basal side of a transiting spermatocyte (205, 
267). Accordingly, the specific depletion of AR in SCs results in spermatogenic arrest 
during meiosis (268, 269). Testosterone suppression in rats and reduced AR activity in 
mice causes precocious detachment of immature germ cells from SCs, leading to an 
absence of mature spermatozoa (139, 270). ES adherens junction proteins, specifically 
those mediating the interaction between SCs and elongated spermatids, are targets of 
androgen suppression (271, 272). The absence of testosterone causes changes in the 
phosphorylation status of several ES-associated proteins, such as β-catenin, modifying 
their structural conformation, activity and function (273). On the other hand, it has been 
reported that the absence of testosterone signaling can cause a blockage of spermiation 
with mature germ cells undergoing phagocytosis by SCs instead of being released into the 
lumen of the seminiferous tubule (270).  
In summary, these studies provide solid evidence to conclude that the presence of 
sufficient testosterone, provided by LCs, is critical for spermatogenesis and that either the 
disruption of AR signaling in SCs or the absence of this sex-steroid causes male infertility 
[reviewed in (265)].  
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1.5.3 GATA factors in the adult testis 
In the adult mouse, both GATA4 and GATA6 can be detected in testicular Sertoli and 
Leydig cells (119). Figure 10 summarizes gonadal Sf1-Cre phenotypes of GATA 
deficiencies discussed below. 
Surprisingly, Gata6 cKO mice generated with Sf1-Cre lack a reproductive 
phenotype, hypothetically due to functional compensatory effects by GATA4 (131). As of 
GATA factors this phenomenon of redundancy has been reported in other tissues (274, 
275).  
The coordinated expression of GATA4 has been implicated in adult testis function 
(119, 130, 246). Interestingly, a proportion of male patients harboring deletions within the 
GATA4 gene suffer from genitourinary anomalies, including hypospadias and bilateral 
cryptorchidism (276). Loss-of-function of GATA4 due to a heterozygous mutation was 
associated with disorders of sex-development in male patients and caused anomalies of 
human testicular development (126). Recent studies using Amhr2 (anti-Mullerian hormone 
type 2 receptor)-Cre and Sf1-Cre revealed that Gata4 cKO mice develop age-dependent 
testicular atrophy with loss of fertility (117, 246). The gradual deletion of Gata4 leads to 
increased permeability of the BTB and the selective loss of late stage (haploid) germ cells 
(246). Further, adult Gata4 cKO mice have a hypoplastic penis and a smaller anogenital 
distance when compared to wild type (WT) mice (117).  
Male GATA4/GATA6 double mutants are infertile due to impaired 
spermatogenesis, exhibit small testes with disorganized seminiferous tubules, and show a 
decreased number of LCs and impaired testosterone production (155).  
 
 
Figure 10 Gonadal phenotypes of Gata4 and Gata6 single and double cKO mice generated with the 
LoxP system using Sf1-Cre. The testes of adult Gata6 cKO mice exhibit no phenotypic 
abnormalities (131). Adult Gata4 cKO show testicular atrophy, vacuolated SCs and suffer 
from impaired spermatogenesis and infertility (117). The dramatic gonadal phenotype of 
male double Gata4 and Gata6 mutants depicts testicular hypoplasia, cryptorchidism, 
depletion of mature sperm, disorganizations in the seminiferous tubules, and impaired 
testosterone production (155). Adrenal-like cells in the testes produce ectopic corticoids, 
allowing the survival of males (156). Modified from (157). 
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Although there is evidence that GATA4 regulates testicular somatic cell 
development and function, its detailed cooperation with signaling pathways and ultimate 
target genes are not well understood, particularly in cells of the adult. Efforts to 
understand the role of GATA4 in adult LC function remain controversial due to 
inconsistent phenotypes. For example, GATA4 depleted progenitors in chimeric mice 
experience a limited capability to differentiate into fetal LCs (130, 277). In contrast, the 
conditional mutagenesis of Gata4 in LCs as early as E12.5 does not alter the expression 
profile of differentiation markers in the fetal or adult testis (117, 130). As reviewed (130), 
cellular heterogeneity, compensatory responses, and other factors hamper the 
interpretation of conditional knockout studies in the testis of the mouse. Less complicated 
experimental models including immortalized cell lines and primary cultures of adult 
testicular cells eventually help to circumvent these limitations. 
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2. Aims of the study 
This doctoral thesis focuses on transcriptional control in the adrenal cortex and testis. 
The presented research addresses three specific aims: 
1.  To study changes in DNA methylation associated with gonadectomy-induced 
adrenocortical neoplasia and to study the in vivo regulatory role of GATA4 during 
tumorigenesis. 
2.  To characterize the impact of Gata4 gene silencing on adult testicular Leydig cell 
function in vitro. 
3.  To explore the molecular mechanisms by which GATA4 regulates adult testicular 
Sertoli cell function and blood-testis barrier integrity in vitro.  
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3. Material and methods 
3.1 Mice  
Investigations involving mice were conducted in accordance with the National Institutes 
of Health guidelines for the care and use of experimental animals and approved by the 
Animal Studies Committee at Washington University in St. Louis, St. Louis, MO, USA 
(Approval No. 20130123 and 20100158).  
3.1.1 Mouse strains (I-IV) 
Gata4+/− C57Bl/6 mice, that harbor a heterozygous deletion in exon 2 of the Gata4 gene 
(278), were mated with DBA2/J or A/J mice (both Jackson Laboratory, Bar Harbor, ME, 
USA) to generate wild type (WT) and Gata4+/− B6D2F1 or B6AF1 hybrids, respectively.  
At weanling age (4 weeks) mice for adrenocortical neoplasms studies were 
anesthetized (75 mg/kg ketamine, ip) and gonadectomized. At defined times mice were 
euthanized by CO2 inhalation, blood (for estrogen measurements) was collected through 
cardiac puncture, and tissue was harvested for further processing.  
3.1.2 Generation of Gata4 conditional knockout mice (II-IV) 
For the generation of conditional knockout (cKO) mice the Cre-LoxP system was utilized. 
Gata4F/F mice [(279), Jackson Laboratory]; were crossed with Amhr2cre/+ B6.129 mice 
[MMRRC, Chapel Hill, NC, USA; (280)]. The resultant Gata4F/+;Amhr2cre/+ mice were 
mated with Gata4F/F mice to generate Gata4F/F;Amhr2cre/+ mice (246, 281). To verify the 
Cre-mediated deletion of exons 3-5 in Gata4F/+;Amhr2cre/+  and cKO animals RT-PCR 
with primers that allow differentiation of transcripts derived from an intact or recombined 
allele was performed. The primer pair F:5’-CCCTACCCAGCCTACATGG-3’ and R:5’-
GAGCTGGCCTGCGATGTCTGAGTG-3’ amplifies a 782 bp band (intact transcript) or a 
shorter 401 bp band when recombined and exons 3-5 are missing. To evaluate the pattern 
of Amhr2-Cre transgene expression within adrenal glands Amhr2cre/+ B6.129 mice were 
mated with ROSA26 flox-stop-flox LacZ reporter mice [Jackson Laboratory; (282)]. 
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3.2 Cell culture 
3.2.1 Murine primary cells (III and IV) 
Murine primary LCs and SCs were isolated from 3 - 6 months old Gata4F/F mice using 
Percoll density separation (283). Primary cells were maintained in 
DMEM/F12+GlutaMAX media (10% FBS, 25 mM HEPES, and 100 mg/L 
penicillin/streptomycin). Primary cell preparations were >90% pure on the basis of 
immunostaining for the SC marker RHOX5 (reproductive homeobox 5) and the LC 
marker 3βHSD.  
3.2.2 Cell lines (III and IV) 
Mouse mLTC-1 Leydig cells (284) were cultured in Waymouth’s medium, supplemented 
with 5% FBS, 10% horse serum, and 100 mg/L gentamicin (all Life Technologies, 
Carlsbad, CA, USA). 
Mouse TM4 Sertoli cells (285) were cultured in DMEM/F12+GlutaMAX media 
supplemented with 10% FBS, 25 mM HEPES, and 100 mg/L penicillin/streptomycin (all 
Life Technologies).  
3.2.3 GATA4 depletion in Leydig and Sertoli cells (III and IV) 
mLTC-1 and TM4 cells (passages 10 to 18) were transiently transfected in the absence of 
antibiotics with a pool of 4 siRNAs targeting Gata4 (5’-AGAGAAUAGCUUCGAACCA-
3’, 5’-GGAUAUGGGUGUUCCGGGU-3’, 5’-CUGAAUAAAUCUAAGACGC-3’, 5’-
GGACAUAAUCACCGCGUAA-3’) or with non-targeting control siRNA (5’-
UGGUUUACAUGUCGACUAA-3’; all from Dharmacon, Lafayette, CO, USA) using 
Lipofectamine RNAiMAX transfection reagent in Opti-MEM (Life Technologies) at a 
final concentration of 0.1 µM. Conditioned media and cells were collected 72 h post-
transfection for further analysis. 
Primary LCs and SCs isolated from Gata4F/F mice were cultured in the presence of 
adenovirus [multiplicity of infection (MOI) = 100] expressing either green fluorescent 
protein (Ad-GFP) or the combination of Cre recombinase and GFP (Ad-cre-IRES-GFP) 
(Vector Biolabs, Philadelphia, PA, USA). Following infection, the cells were maintained 
in serum free DMEM/F12+GlutaMAX for 48h before RNA/protein extraction. 
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3.2.4 Transmission electron microscopy (II and IV) 
TM4 cells were plated on 4-well Matrigel coated Permanox chamber slides (Sigma, St. 
Louis, MO, USA). The samples were 72 h later fixed using modified Karnovsky fixative 
(2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M cacodylate buffer, 1 h), post-
fixed (2% OsO4 in 0.1M sodium cacodylate buffer; 1 h), dehydrated, and embedded in 
epon. Sections (90 nm) were stained with uranyl acetate and lead citrate and examined 
with a 1400EX electron microscope (JEOL, Tokyo, Japan).  
3.2.5 Trans-epithelial resistance measurements (IV) 
To assess epithelial barrier integrity TM4 cells were transfected with siRNA (see 3.2.3) 
and plated at a density of 0.5 x 106 cells/cm2 on matrigel coated bicameral culture units. 
Cells were incubated (humidified CO2 incubator; 37°C) and every 12 hours the trans-
epithelial resistance (TER) was measured using the Millicell Electrical Resistance System 
(286). 
3.3 Gene expression analysis 
3.3.1 Laser capture microdissection (LCM) (I) 
Adrenal glands were harvested 3 months post OVX, fresh frozen, and cryosectioned. 
Sections (10 µm) were collected on PEN-Membrane slides (Leica, Wetzlar, Germany) and 
fixed in ice-cold acetone (5 sec), stained with H&E, and dehydrated. LCM was performed 
using a Leica LMD6000 microscope. Dissectates were collected in a buffer containing 
SDS and proteinase K for genomic DNA isolation (NucleoSpin Tissue XS columns, 
Clontech, Mountain View, CA, USA). Genomic DNA was quantified with the Quant-it 
dsDNA high sensitivity kit and a Qubit fluorometer (both Invitrogen, Carlsbad, CA, 
USA). 
3.3.2 Methylation analysis (RRBS and LCM-RRBS) (I) 
LCM-derived DNA samples were incubated overnight at 37°C with MspI enzyme. 
Fragment ends were filled in and an adenosine added using Klenow fragment and the 
addition of dNTP’s. Illumina adapters were ligated overnight to the ends of the DNA 
fragments using T4 DNA ligase (Adapter I: ACACTCTTTCCCTACACGACGCTC 
TTCCGATCT; Adapter II: P-GATCGGAAGAGCACACGTCTGAACTCCAGTCAC, 
P=phosphate). Subsequent samples were treated with bisulfite using the EZ DNA 
methylation Gold kit (Zymo, Freiburg, Germany) and sample specific indexes were 
incorporated via PCR with indexed primers (F:AATGATACGGCGACCACCGAG 
ATCTACACTCTTTCCCTACACGACGCTCTTCGATCT; R:CAAGCAGAAGACGGC 
ATACGAGATNNNNNGTGACTGGAGTTCAGACGTGTGCTCTTCCGA, N=index). 
Samples were pooled and size selected using an agarose gel. Fragments of 150-350 bp in 
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size were extracted and purified using MinElute columns (Quiagen, Hilden, Germany). 
The final library was enriched via PCR using universal primers (Pool1: 
CAAGCAGAAGACGGCATACGAGAT, Pool2: AATGATACGGCGACCACCGAGA 
TCT) and sequenced on an Illumina HiSeq 2000 platform. 
Methylation analysis was performed using the July 2007 (NCBI377mm99) build of 
the mouse genome. About 25 million reads per sample were aligned to the cytosine-poor 
strand reference with the bisulfite mode of MAQ (287) or aligned to the reduced reference 
via RRBSMAP (288). Percent methylation was determined by identifying the portions of 
reads that had an unconverted cytosine at the CpG position relative to the total reads. 
Methylation status of cytosine was analyzed for CGIs (region > 200bp with GC content ≥ 
50% and an ‘observed to expected’ ratio of >0.6) and promoters (2kb region centered 
around the transcription start site). The DNA methylation status of all CpGs, within the 
promoter region of all RefSeq genes, was compared to identify differentially methylated 
promoters in adrenocortical neoplasia. Promoters with at least 10% methylation difference 
were analyzed using R and considered statistically significant if P<0.05 (false-discovery 
rate; FDR=5%). DNA methylation data is available online and accessible via NCBI gene 
Expression Omnibus (GEO) number GSE45361. 
3.3.3 Real time qRT-PCR (II – IV) 
RNA was isolated (NucleoSpin RNA/Protein kit, Machrey-Nagel, Düren, Germany or 
TRIzol, Invitrogen) and reverse transcribed (SuperScript VILO cDNA Synthesis kit; Life 
Technologies). qRT-PCR was performed using SYBR GREEN I (Invitrogen) and 
expression was normalized to the housekeeping genes Actb and/or L19. Primer pairs are 
listed in Table 2. 
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Table 2  Primers for qRT-PCR 
 
F: GCGTGACATCAAAGAGAAGC
R: AGGATTCCATACCCAAGAAGG
F: TGCAAGTAGTTGAAGGTGTTGC
R: CTCTGATCCCCTTTCCCTGTG
F: AGGGAGAACCAGGTCAACCA
R: TCTCCCAGGAGGGCCTTG
F: GACCTCTCTGCTCACCTTCC
R: CCACTTTCGTATCCCTCCGTA
F: TCATGCTGATCTTCCGCATCC
R: GAAGCGGTAGTGGGACACC
F: AGGGGTGGACACGACCTCCA
R: TGCTGGCTTTGAGGAGTGGAACC
F: CCAGATGGTGACTCTAGGCCTCTTGTC
R: GGTCTGTATGGTAGTCAGTATCG
F: GACACCCCAATCTCGATATGTT
R: CTTAATGAGGGGCCGGTTGA
F: CCCTACCCAGCCTACATGG
R: ACATATCGAGATTGGGGTGTCT
F: TTGCTCCGGTAACAGCAGTG
R: GTGGTCGCTTGTGTAGAAGGA
F: GTCCGGTACTACCTCGGTGA
R: CTTCAGAGCCGTGGTGAACT
F: TTTCCTTCCTCTTCCGAGCAC
R: AGGTTCAAGCTGAAGTTGTTGA
F: CCGAGCTGAAGGATGACCAA
R: CCCCTTTTCTGAGCCGTCC
F: AGGTTCTCGCAGCACCTTTTT
R: CATCGCCTGCTCCGGTAATC
F: TGGACAAAGTATTCCGACCAGA
R: GGCACACTTGCTTGAACACAG
F: ATGTCTCCCAGGCTATCCTTTTC
R: CGTATGTGTTGGGATGGCCGGA
F: CACGCAGCCTGTGGAGACCC
R: CGCTGGCGCTGAGAAGCCT
F: GAAATCGCCAATGCCAACTC
R: TCTTAGACCTGCGAGCCTCA
F: ACATGCCAGCGAGTGTGTAA
R: AGTCACAAGGAAGGCACTCG
F: GGTGGACAGGGAATGTACGG
R: GAGCGACCTCATCGTCCTTC
F: CTCCAGAGTTGTCAGGGTCG
R:  TGAGAGATATGTCGGGCGAGG
F: CGCCCGACTATCTCTCACCTA
R: GACAGATTGAGGAGGTGTCAAA
F: ACACCGCAAGAAATAACTCCG
R: AGGAGGACAATCAAGTTCTCCA
F: GACTCTATGGCTGCCTGGAC
R: TCGTTCTGGTGGGTGATGTG
F: TCGTGGTGGTAGTCGTCGTA III
R: CTCCCTCTGGTCCTCTTGCT
F: CCGTCGCCACTGTCTATCAA
R: CTCTGCATGTACCAGCTCTGA
F: TTTCCAGGCCAACCAATCCA
R: GGCCCTCATGGCATTCTTGA
F: CTGCCCTGAATGTGATTGTCG
R: CGTTGGACTGCAAATCTCCG 
F: GTTCTCGGACCACATCGAGGGACA
R: TGCAGGACAGGTTCCAGGGACAAA
F: GCGTGGTGTTTGCTCTGTTC
R: GCGTGGTGTTTGCTCTGTTC
F: CACGCAGCCTGTGGAGACCC
R: CGCTGGCGCTGAGAAGCCT
F: GCGGGGCGGACGCTT
R: ATTGCTGTGCTCTTAGCGGC
F: CCCTCACACTCAGATCATCTTCT
R: GCTACGACGTGGGCTACAG
NM_013743.2
73 NM_175283.3 III
231 NM_001163574.1 IV
134 NM_013564.7 III
195 NM_001291071.1 III & IV
181 NM_023418.2 III & IV
100
129 NM_001110791.1
NM_008291.3
NM_008293.3
106 NM_013582.2
NM_005084
130
150 NM_013582 II
NM_010564.4 II & III
134 NM_013564.7 III
405
II, III & IV
200 NM_001146100.1 III & IV
III
III
NM_010258.3
III & IV
138
250
II & III
167 NM_008092.3 III & IV
NM_007809.3307
164 NM_019779.3 III
Pdk4
Pfkp
Pgam1
185 NM_008155.4
Lhcgr
Lhcgr
Mc2r
Mmp23
Nr5a2
Pdk3
Hsd3b1
Inha
Insl3
L-19
Lamc1
Ldhb
Gls2
Gpi1
Hk1
Hsd17b3
Cyp17a1
Gata4
Gata4
Cx30.2
Col4a5
Gata6 
NM_008092.3
Csk
Reference
Cyp11a1
Actb
Cldn12 IVNM_001193659.1
II, III & IVNM_007393.2
168 NM_011985.2 IV
Article #
103 NM_008560
Star
Tjp1
Tnf
Gene Oligonucleotide sequence (5' → 3') Size (bp)
104
87
187
198
Srd5a1
61 NM 013693 IV
245 NM_001163155.1 IV
161 NM_010683.2
II
II
186 NM_001033264.3 IV
IVNM_001302765.1118
IV
II, III & IV
III
IV
191 NM_145630.2 IV
171 NM_001304761.1 IV
149 NM 178596.2 IV
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3.3.4 Microarray analysis (III and IV) 
RNA was isolated from mLTC-1 and TM4 cells 72 h after transfection with Gata4 or non-
targeting siRNA using NucleoSpin RNA/Protein kit and purified with NucleoSpin RNA 
Clean-up XS kit (both from Machrey-Nagel). Array hybridization was performed using an 
Illumina MouseWG-6 v2.0 oligonucleotide BeadChip. Data was background corrected 
using BeadStudio software (Illumina, San Diego, CA, USA); quantile normalization and 
log2 transformation were performed using the BeadArray Bioconductor package (289). 
Differentially expressed genes were identified using LIMMA [linear models for 
microarray data (290)] with Benjamini-Hochberg correction. Expression levels with at 
least 1.5x difference and a FDR below 5% were considered as significantly differentially 
expressed. Microarray data was subjected to average linkage clustering with uncentered 
correlation using Cluster (291). Gene set enrichment analysis of the differentially 
expressed genes was performed using GOstats Bioconductor package (292).  
3.3.5 Western Blotting (III and IV) 
Protein was isolated from cell cultures with the NucleoSpin RNA/Protein kit (Machrey-
Nagel), size separated using SDS-PAGE and blotted onto a PVDF membrane (Invitrogen). 
The Immun-Star WesternC kit (Bio-Rad, Hercules, CA, USA) was used for detection. 
Antibodies are listed in Table 3. 
3.3.6 Immunostainings (II – IV) 
mLTC-1, TM4 cells, and primary cells were grown on 4-well glass Lab Tek® Chamber 
Slides (Sigma) and fixed 24 or 72 h post-transfection with 4% paraformaldehyde in PBS. 
Adrenal glands were fixed in the same way and embedded in paraffin and sectioned. 
Samples were subjected to immunoperoxidase staining (Vectastain Elite ABC kit; Vector 
Laboratories, Burlingame, CA, USA) following rehydration, and antigen retrieval using 
the antibodies listed in Table 3. Slides were counterstained with hematoxylin and eosin 
and evaluated by light microscopy. 
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Table 3 List of antibodies 
 
3.3.7 X-gal staining (II) 
Adrenal glands were harvested, fixed (0.2% glutaraldehyde in PBS; 15min), 
permeabilized (100 mM potassium phosphate, 0.02% Nonidet P-40, and 0.01% sodium 
deoxycholate; 5-15 min), and then incubated in 0.5 mg/ml X-gal (Promega, Madison, WI, 
USA) at 37°C overnight.  
3.4 Metabolic analysis   
3.4.1 Hormone measurements (II and III) 
Serum estrogen levels were measured according to the instructions using commercially 
available ELISA kits. The estrone (E1) sulfate kit was purchased from Endocrine 
Technologies (Newark, CA, USA) and the estradiol (E2) kit from BioCheck (Foster City, 
CA, USA).  
Conditioned media samples of mLTC-1 cells were used to measure steroid levels by 
LC-MS/MS. For steroid separation and quantification an Agilent Series HPLC system 
connected to a mass spectrometer (Agilent 6410 Triple Quadrupole LC/MS) was used. 
Species Method and dilution 
* Santa Cruz Biotechnology, Santa Cruz, CA, USA IHC = Immunohistochemistry
** Jackson ImmunoResearch Laboratories, West Grove, PA, USA ICH = Immunocytochemistry
WB = Western Blot
Antigen Reference # Article #
GATA4 sc-1237 * II, III, IVgoat IHC & ICH (1: 200); 1:1000 (WB)
Gremlin sc-18274 * II
Lactoferrin sc-14434 * II
goat
goat
IHC (1: 200)
IHC (1: 200)
III, IV
TJP1 sc-10804 * IV
3β-HSD sc-28206 * III, IV
rabbit
rabbit
WB (1:1000)
anti-goat 
biotynylated IgG sc-2020 * IV
anti-goat 
biotynylated IgG 305-035-003 ** II
III, IV
donkey IHC (1:1000)
donkey WB (1:10000); ICH (1:200)
RHOX5 goat sc-21650 * ICH (1:200)
ICH (1:200)
Actin goat  sc-1616 * WB (1:5000); 1:200 (ICH)
IVWB (1:1000); ICH (1:200)sc-2004 *goatanti-rabbit IgG
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3.4.2 Metabolomic profiling (III and IV) 
At 72 h post transfection, ~ 2 million mLTC-1 or TM4 cells per sample were quenched in 
liquid nitrogen. Metabolites were extracted, separated with Acquity UPLC, and analyzed 
using XEVO TQ-S Triple Quadrupole liquid chromatography/mass spectrometry (LC/MS; 
Waters Corporation, Milford, MA). A total of 96 (mLTC-1) or 110 (TM4) metabolite 
concentrations were measured and data sets were analyzed using Metaboanalyst software. 
3.4.3 Quantification of secreted metabolites (III and IV) 
Conditioned cell culture media of mLTC-1 and TM4 cells was collected 72 h post 
transfection and glucose, lactate, and ammonium concentrations were measured with the 
Konelab Arena 20 XT machine (Thermo Electron Oy, Helsinki, Finland). 
3.4.4 ATP assay (III) 
27 hours post siRNA transfection mLTC-1 cells were treated for 4 hours with 20 mM 2-
deoxy-D-glucose (2DG; Caymen Chemical Company, Ann Arbor, MI, USA), followed by 
a 1 h incubation with 20 mM dichloroacetic acid (DCA; Sigma). Cellular ATP levels were 
quantified using ATPlite Luminescence Assay System (PerkinElmer, Waltham, MA, 
USA). 
3.5 Statistical analysis  
If not indicated differently, numerical data herein are represented as mean ± SD. Statistical 
significance was determined using the student’s t-test or when appropriate, one-way 
ANOVA followed by Dunnett’s test. Statistical significance was set at *, P<0.05, and **, 
P<0.01.  
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4. Results and discussion 
4.1 Gonadectomy-induced adrenocortical neoplasia (I & II) 
4.1.1 GDX induces the formation of adrenocortical neoplasms  
Following GDX and the ensuing rise of serum gonadotropins, cells located in the 
subcapsular region of the mouse adrenal cortex transform into sex steroid-producing 
neoplasms. Susceptible strains include DBA/2J and the hybrid strains B6D2F1 and 
B6AF1 [reviewed in (153)]. Mice were gonadectomized and 3-12 months later tissue and 
blood were collected to study the DNA methylation profile of GDX-induced 
adrenocortical neoplasms (see 4.1.2) and the in vivo regulatory role of GATA4 during 
tumorigenesis (see 4.1.3).  
To study the microscopic appearance of the tumors the adrenal glands of B6D2F1 
and B6AF1 mice were harvested 3 or 4 months post GDX and paraffin sections were 
subjected to H & E staining (Figure 11). As expected the sections revealed the presence of 
subcapsular neoplasms composed of spindle-shaped type A cells (arrowheads) and sex 
steroidogenic type B cells (arrows). Type A cells resemble stromal cells of the 
postmenopausal ovary and Type B cells express the gonadal-like markers, such as Lhcgr, 
Inha, Cyp17a1, and Cyp19a1 (153). 
 
 
 
Figure 11  GDX-induced adrenocortical neoplasms of the mouse. Weanling wild type B6D2F1 or 
B6AF1 mice were ovariectomized (OVX) and adrenal glands were harvested, cross-
sectioned and H&E stained 3 or 4 months later. Subcapsular neoplastic tissue consists of 
type A (arrowhead) and type B cells (arrows).  
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4.1.2 DNA methylation in GDX-induced adrenocortical neoplasia 
Because stem/progenitor cells in the murine adrenal cortex exhibit epigenetic variability it 
has been speculated that epigenetic modifications, such as DNA methylation have an 
impact on the transformation of normal cells of the adrenal cortex to sex steroid-producing 
neoplasms (181, 182). The phenotypic plasticity of these stem/progenitor cells and their 
ability to respond to hormonal changes following GDX is thought to be affected by 
preexisting epigenetic alterations (183). However, the identification of DNA methylation 
signatures in complex but small tissues, such as neoplasms of the murine adrenal cortex, 
has been challenging (293). Cell isolation techniques such as LCM enable researchers to 
separate specific cell types from heterogeneous tissues (294). However, the DNA yields 
derived from LCM samples are too small for described sensitivity limits of the gold-
standard method for genome-wide DNA methylation analysis (RRBS). Traditional RRBS 
is capable of analyzing samples with DNA amounts of 10-300 ng but not less (295).  
4.1.2.1 LCM-RRBS accurately measures genome wide DNA methylation 
To investigate the epigenetic regulation of GDX-induced adrenocortical neoplasia, an 
enhanced method capable of analyzing small amounts of genomic DNA (as low as 1 ng) 
was developed by our collaborators (Laboratory of Prof. Mitra, Washington University in 
St Louis, St. Louis, MO, USA). The workflow of this novel method called LCM-RRBS is 
shown in Figure 12 and includes the introduction of a sample specific index, allowing to 
pool samples before the size selection step. First, genomic DNA is isolated via LCM and 
digested with a methylation-insensitive restriction enzyme, MspI. This enzyme targets the 
3’CCGG5’ sequence and cleaves the phosphodiester bond upstream of CpGs. Resulting 
sticky ends require end repair (adenylation), and the subsequent ligation of sequencing 
adapters allows PCR amplification and sequencing. Cytosines of adapters are methylated 
in order to prevent deamination during bisulfite treatment. Bisulfite treatment leads to the 
conversion of unmethylated cytosines into uracil due to deamination. When performing 
traditional RRBS, tissue samples are size selected directly after adapter ligation and then 
run in individual gel lanes. This approach requires separate extraction, resulting in high 
amounts of DNA sample loss. By introducing a sample specific index, samples can be 
pooled before size selection and processed in parallel, reducing DNA loss, time, and cost. 
Before applying LCM-RRBS in a biological setting (analyzing the methylation profile of 
adrenocortical neoplasms), we evaluated its performance by benchmarking against 
traditional RRBS (I). Results obtained from LCM-RRBS were similar to those from 
RRBS. LCM-RRBS accurately measured the DNA methylation status of both, CGIs 
(n=18448; r=0.98) and core promoters (n=8500; r=0.94).  
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Figure 12  LCM-RRBS workflow. Normal tissue (large lipid droplets; green) and GDX-induced 
adrenocortical neoplastic tissue (fewer lipid droplets, red) are dissected using LCM. 
Genomic DNA is extracted and digested with the help of a methylation-insensitive enzyme, 
end repaired, and ligated with Illumina platform specific, methylated adapters. Following 
bisulfite conversion each sample is indexed by introducing sample specific nucleotide 
sequences (shown in red or green) via low-cycle PCR. Sample libraries are pooled, size 
selected and after DNA gel extraction amplified and finally sequenced on the Illumina 
platform. 
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4.1.2.2 Genes with putative roles in gonadal or adrenocortical development are 
differentially methylated in GDX-induced adrenocortical neoplasia 
To study the epigenetic regulation of GDX-induced adrenocortical neoplasia we applied 
LCM-RRBS to samples derived from neoplastic and normal cells of the adrenal cortex. 
The adrenal glands of three OVX mice were fresh frozen, cryosectioned and stained. 
When performing LCM, normal cells of the zF had large lipid droplets that were easily 
recognized, whereas neoplastic cells distorted the normal adrenal zonal structure and 
contained fewer lipid droplets (Figure 12). In this multiplexed experiment the methylation 
status of >13.000 promoters and >13.000 CGIs was interrogated across an average of 
>800.000 CpGs in each sample. By analyzing six samples (three neoplastic and three 
normal representing three individual mice), we identified 37 promoters that were 
significantly hypomethylated and 8 promoters that were significantly hypermethylated in 
the neoplastic tissue when compared to normal adjacent adrenocortical tissue (P < 0.05).  
The top hypermethylated and hypomethylated genes are listed in Table 4. 
Interestingly, many of these genes have been previously implicated in cell fate 
determination and differentiation. For instance, Tinagl1 (tubulointerstitial nephritis 
antigen-like 1), a gene involved in adrenal zonation (296), was found to be 
hypermethylated in the neoplastic tissue. In contrast, other factors implicated in gonadal or 
adrenal development, including Foxs1 (forkhead box S1), Igfbp6 (insulin-like growth 
factor binding protein 6), and Wdr63 (WD repeat domain 63) were found to be 
hypomethylated in the diseased tissue (296, 297).   
RESULTS AND DISCUSSION 
 48 
Table 4  Hyper- and hypomethylated genes in GDX- induced adrenocortical neoplasms 
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Figure 13 illustrates the promoter regions of four genes differentially methylated in 
adrenocortical neoplasia.  
 
Figure 13 Examples of differentially methylated promoters in GDX-induced neoplasms. Colored 
boxes represent individual CpG dinucleotides within a 2 kb region of the transcription 
starting site. High, moderate, and low methylation levels are shown in yellow, black, and 
blue, respectively. Undetermined methylation levels are shown in grey color. Percentages 
on the right of each heatmap represent mean methylation of each region interrogated. The 
region of the promoter interrogated by LCM-RRBS is indicated with red boxes for each 
gene. 
The identified changes in DNA methylation close to the transcription start site can 
lead to altered gene expression (298, 299). Further indicating the importance of the 
methylation status in terms of gene regulation is that the hypomethylated genes Wdr63, 
Foxs1, and Igfp6 were shown in follow up studies to be expressed in GDX-induced 
neoplasia, whereas their expression was absent in adjacent normal tissue (112, 179).  
Foxs1 encodes a transcription factor found in SCs and periendothelial cells of the 
fetal testis (297). Male knockout mice are fertile but accumulate blood in the developing 
testis (297). Interestingly, Foxs1 is also expressed in gonadal-like cells appearing 
subcapsular in the adrenal glands of Gata6 cKO mice generated with Sf1-Cre (131). 
Consistent with these findings and the identified hypomethylated status, indicating active 
transcription, other investigations showed that Foxs1 is strongly expressed in neoplastic 
adrenocortical cells but weakly expressed in adjacent normal tissue (179). 
In the same study another hypomethylated gene, Igfbp6, showed the same 
expression profile as Foxs1 in neoplastic and normal adrenal cortical cells (179). Igfbp6 
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encodes for a family member of insulin-like growth factor binding proteins (IGFBPs) that 
regulate the interaction of insulin-like growth factors (IGFs) with their receptors on the 
cell surface. IGFBP6 was shown to inhibit the actions of IGF2, a factor known to impact 
growth, differentiation, and function of adrenocortical cells (300, 301). IGFBP6 may serve 
as an insulator by blocking the activity of IGF2 in GDX induced-neoplasia and thereby 
promoting gonadal-like differentiation over adrenocortical differentiation.  
Taken together, the observed changes in DNA methylation suggest that neoplastic 
cells in the adrenal cortex may arise owing to aberrant gene regulation and expression of 
genes normally silenced in this endocrine tissue.  
4.1.3 GATA4 drives GDX-induced adrenocortical neoplasia  
GDX-induced neoplasms of the adrenal gland exhibit a variety of histological and 
biochemical hallmarks of normal gonadal tissue. One of those hallmarks is the expression 
of GATA4, normally silenced and thus absent in corticoid producing cells of the adult 
adrenal gland (36, 180). However, at the time of investigation proof of its direct role in the 
modulation of GDX-induced adrenocortical neoplasia has still been lacking. We assessed 
the impact of loss-of-function mutations in the murine Gata4 gene on OVX-induced 
adrenocortical neoplasia. Mice with germline null mutations in both alleles of the Gata4 
gene die during embryonic development (43, 44, 279, 302). Therefore we studied the in 
vivo role of GATA4 in adrenocortical tumorigenesis in Gata4 haploinsufficient (278, 303) 
and conditional knockout mice (246, 281). 
4.1.3.1 Consequences of germline Gata4 haploinsufficiency 
Gata4 haploinsufficiency enhances GDX-induced adrenocortical tumor 
development  
To investigate the impact of GATA4 haploinsufficiency on adrenocortical tumorigenesis, 
we crossed Gata4+/− C57Bl/6 mice with DBA/2J mice and analyzed the phenotype of 
resultant wild-type (WT) and Gata4+/− B6D2F1 offspring. Gata4+/− C57Bl/6 mice harbor a 
deletion mutation of Gata4 that includes the translation start site within exon 2 (278, 281, 
304). To demonstrate that the impact of Gata4 haploinsufficiency is not limited to a single 
hybrid strain we additionally crossed C57Bl/6 and A/J F1 mice and examined the B6AF1 
offspring. Like their parental strains, both hybrid strains (B6D2F1 and B6AF1) develop 
adrenocortical neoplasia post OVX (305, 306) (Figure 11 and Figure 14A-D). 
The adrenocortical tumors of both WT hybrid mouse strains exhibited positive 
immunoreactivity for nuclear GATA4 antigen in both, type A (arrowheads; Figure 14A) 
and type B cells (arrows; Figure 14B). Only sex steroidogenic type B cells stained for 
gremlin, a bone morphogenic protein antagonist described to play a role in ovarian 
granulosa cell function (307) (Figure 14C,D). Adrenal glands from B6D2F1 OVX 
Gata4+/- mice exhibited only rare, small tumor patches that did not invade deep into the 
adrenal cortex and consisted of GATA4 expressing type A cells only (arrowheads Figure 
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14E,G). There were no morphologically recognizable type B cells present (Figure 
14E,G). In an even more drastic manner Gata4 haploinsufficiency mitigated OVX-
induced adrenocortical tumor formation in B6AF1 mice, as there were no neoplastic cells 
visible (Figure 14F,H). In the two hybrid strains immunostaing for gremlin was negative 
(Figure 14G,H). 
 
Figure 14  Gata4 haploinsufficiency mitigates ovariectomy-induced adrenocortical tumor formation. 
Microscopic appearance of adrenal glands from WT (A-D) and Gata4+/- (E-H) B6D2F1 (3 
mo post OVX) and B6AF1 mice (4 mo post OVX). Tissue cross sections were immunostained 
with anti-GATA4 (A,B,E,F), or anti-gremlin (C,D,G,H). Arrowheads indicate type A cells 
and arrows the presence of steroidogenic type B cells. (I), Neoplastic tissue coverage in the 
cross sections of adrenal glands derived from B6D2F1 6 mo post OVX was significantly 
reduced in Gata4+/- mice when compared to WT mice (n=4-6; P<0.001). OVX, ovariectomy. 
The cross-sectional area of cortex tissue occupied by type A and type B cells 
(neoplastic cells) at varying times after OVX was measured to quantify differences in 
neoplastic tumor formation between WT and Gata4+/- mice (Figure 14I). Whereas 
neoplastic cells covered 27% of the cross-sectional area 6 months post OVX in WT mice, 
Gata4 haploinsufficiency reduced the area occupied by neoplastic cells significantly (n=4; 
P<0.001). This reduction in tumor size was mainly due to a decrease in type B cell 
RESULTS AND DISCUSSION 
 52 
number (132 ± 104 type B cells in WT B6D2F1 mice vs. 2 ± 1 in Gata4+/- mice; P < 
0.05). Hyperplasia as seen in OVX B6D2F1 Gata4+/- mice, harboring only type A cells, 
resembles a feature of older WT mice and is not considered tumorous (307). 
One could argue that haploinsufficiency for Gata4 has an impact on the function of 
the anterior pituitary gland since this transcription factor and other family members have 
been implicated in its development and function (308, 309). Quantification of basal and 
post-OVX serum FSH and LH levels in both B6D2F1 and B6AF1 mice revealed that there 
was no difference in pituitary gland function between WT and Gata4+/- mice. These 
results manifest that the reduction in tumor formation seen in Gata4+/- mice is not due to 
altered gonadotrope function. 
Gata4 haploinsufficiency impairs adrenocortical estrogen production and the 
expression of gonadal-like markers  
To investigate if germline Gata4 haploinsufficiency in B6D2F1 mice has an impact on 
adrenocortical sex steroid production we measured 12 months post OVX serum E2 and E1 
sulfate levels. Indicative for a reduced adrenocortical sex steroid production due to 
GATA4 haploinsufficiency estrogen levels were greater in WT than in Gata4+/- mice 
(Figure 15A,B). Ectopic sex steroid production after GDX can be assessed by examining 
tissues that undergo morphological changes in response to circulating estrogens, including 
the uterus (310). Older OVX WTB6D2F1 mice exhibit estrogenic stimulation of the uterus 
and by 12 months post OVX every mouse (n=5) had enormously enlarged uterine horns 
(Figure 15C-E). In turn, Gata4+/- mice (n=4) did not show any morphological evidence of 
ectopic estrogen production and exhibited atrophic uteri (Figure 15D,F). 
Immunoreactivity for lactoferrin, an estrogen-responsive marker (311), was evident in 
uterine epithelial cells of WT mice (Figure 15G) but completely absent in Gata4+/- mice 
(Figure 15H).  
Next, we assessed the expression of gonadal-like markers in the adrenal cortex of 
germline Gata4 haploinsufficient mice that underwent GDX 5 months ago. qRT-PCR 
revealed that OVX-induced an increase in the expression levels of sex steroidogenic 
differentiation markers GATA4, Cyp17a1, Lhcgr, and Inha in WT B6D2F1 (Figure 15I) 
and B6AF1 mice. These results are in accordance with previous studies on other 
susceptible strains (112, 153, 312-314). Gata4 haploinsufficiency significantly reduced 
this OVX-induced effect for all gonadal-like markers and lower sex steroidogenic 
transcripts were measured (Figure 15I). OVX in both WT and Gata4 haploinsufficient 
mice had no influence on the expression of adrenocortical markers (melanocortin 2 
receptor (M2CR) and GATA6) when compared to control mice with intact ovaries 
(Figure 15I).  
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Figure 15  Impact of Gata4 haploinsufficiency on extragonadal estrogen production and the 
expression of gonadal-like markers in the adrenal gland. (A,B) Serum E2, and E1 sulfate 
levels of the indicated genotypes were measured 12 mo post OVX. Boxes mark the 
interquartile range and individual dots represent single measurements. Whiskers represent 
the first and fourth quartiles and the dashed lines indicate the mean. (C-H) 12 mo post OVX 
the uteri of WT and Gata4+/- mice were analyzed for evidence of extragonadal sex steroid 
stimulation. The uteri of WT mice were heavier (C) and enlarged (D,E) when compared to 
Gata4+/- mice that exhibit atrophic uteri (C,D,F). Estrogen responsive marker lactoferrin 
stained epithelial cells of the uterus in WT mice (G) 12 mo post OVX but not the ones in 
Gata4+/- mice (H). Bars, 2 mm (D), 300 µm (E,F), 75 µm (G,H). (I) The mRNA expression of 
gonadal- and adrenal-like markers in the adrenal glands of the indicated genotypes was 
analyzed via qRT-PCR. The relative expression (mean ± SD) of individual markers in OVX 
adrenal glands vs. adrenal glands of mice with intact ovaries are blotted using a 
logarithmic scale (n=4; P<0.001). 
4.1.3.2 Conditional deletion of Gata4 in nascent adrenocortical neoplasms  
Gata4 conditional knockout (cKO) mice of both genders have reduced fertility associated 
with defects in gonadal somatic cell function (246, 281). Accordingly, we hypothesized 
that the recombination of Gata4F using Amhr2-Cre would impair the appearance of 
gonadal-like neoplastic cells in the adrenal glands of GDX mice in a Gata4F dose-
dependent fashion.  
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Generation of Gata4 cKO mice 
For the conditional deletion of Gata4 in nascent tumor cells of the adrenal cortex we used 
the Cre-LoxP recombination system (Figure 16A). Similar to other strains, B6.129 mice 
develop adrenocortical neoplasia as response to GDX. Mice bearing floxed alleles of 
Gata4 (Gata4F/+) were mated with mice harboring a knock in allele for Amhr2-Cre. 
Recombination of LoxP sites flanking exons 3-5 in the Gata4 gene results in a null allele 
(279, 315). For the generation of cKO mice, Gata4F/F mice were crossed with B6.129 
Amhr2Cre/+ mice and the resultant Gata4F/+; Amhr2cre/+ mice were mated with Gata4F/F 
mice. Offspring with the genotype Gata4F/F; Amhr2Cre/+ is referred to as Gata4 cKO in the 
following. 
To confirm the deletion of the Gata4 gene through Amhr2-Cre-mediated 
recombination in the adrenal gland of OVX mice we utilized a qualitative RT-PCR assay 
that allows the differentiation between the transcripts of intact and recombined Gata4 
alleles (246) (Figure 16B). Whereas the adrenal glands of Gata4F/+ mice exhibited a 782-
bp band reflecting the transcription of the intact allele, RT-PCR analysis of 
Gata4F/+;Amhr2Cre/+ mice yielded in the amplification of both, the 782-bp fragment and a 
smaller 401-bp fragment. The latter fragment is derived from the recombined allele and 
lacks exons 3-5 (Gata4 Δex3-5) (Figure 16B).  
 
 
Figure 16  Cre-mediated recombination results in deletion of exons 3-5 in the Gata4 gene. (A) 
Illustration of the Cre-LoxP recombination system. Crossing of mice with the indicated 
genotypes leads to the expression of dysfunctional GATA4 protein in cells expressing 
Amhr2. In these cells the transcription of Amhr2 is linked to the active transcription of the 
Cre recombinase enzyme that catalyzes the recombination of LoxP sites, resulting in the loss 
of exon 3-5 of the Gata4 gene. (B) RT-PCR analysis of adrenal RNA 3 mo post OVX using 
primers capable of distinguishing transcripts derived from an intact Gata4F allele vs. 
recombined alleles that lack exons 3-5. 
To assess the expression pattern of the Amhr2-Cre transgene within the adrenal 
gland of mice post OVX we crossed B6.129; Amhr2Cre/+ mice with ROSA26 Flox-stop-
Flox LacZ reporter mice (Figure 17A). In response to Cre recombinase mice that harbor a 
recombined allele are lacking the stop side and consequently express β-galactosidase 
(282). Whole-mount X-gal staining is used to visualize active Cre recombinase in Amhr2 
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expressing cells. Analysis of adrenal glands from OVX R26R; Amhr2Cre/+ mice revealed β-
galactosidase activity in very discrete patches of subcapsular cells (Figure 17B). 
Subsequent histological analysis of cross-sectioned adrenal glands showed positive X-gal 
staining in neoplastic cells, but not in adjacent normal cells of the adrenal cortex (Figure 
17C). Transmission electron microscopy revealed that crystalloids, indicative of positive 
X-gal staining, in both type A (Figure 17D) and type B (Figure 17E) cells of the tumor. 
Control mice that did not undergo OVX showed no X-gal staining. 
 
 
Figure 17  Ovariectomized R26R; Amhr2Cre/+ mice exhibit adrenocortical tumors that express 
Amhr2-Cre. (A) Illustration of the Cre-LoxP recombination system in R26R reporter mice. 
Crossing of mice with the indicated genotypes leads to the deletion of a stop site and LacZ 
gene expression in Amhr2 expressing cells. In these cells X-gal staining leads to a positive 
result, indicating active Cre recombination and expression of Amhr2. (B-E) Adrenal glands 
were harvested 5 mo post OVX and subjected to whole mount X-gal staining. Cross-sections 
were subjected to light microscopy (C) or transmission electron microscopy (D,E). 
Crystalloids (arrows) indicating positive X-gal staining were found in both, type A (D) and 
type B cells (E). Bars,100 µm (B-C), 2 µm (D,E).  
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GATA4 cKO mice show reduced tumor formation and altered expression of 
steroidogenic markers in nascent adrenocortical neoplasms  
The adrenal glands of Gata4F/F mice showed tumor invasion into the cortex at 3 months 
post OVX (dark subcapsular patches in Figure 18A). The tumors were composed of type 
A (arrowhead) and steroidogenic type B cells (arrow in Figure 18B). However, the 
neoplasms found in the adrenal glands of cKO mice were small and did not invade as 
deeply into the cortex (Figure 18C). These tumors were exclusively composed of type A 
cells found close to the capsule (arrowhead in Figure 18D).  
 
Figure 18 Reduced tumor formation and mRNA expression levels of gonadal-like markers in Gata4 
cKO mice. (A-D) Adrenal glands were 3 mo post OVX sectioned and immunostained with 
GATA4 antibody. Tumors of Gata4F/F (B) mice invade deep into the organ and contain type 
A (arrowheads) and type B (arrow) cells. Tumors found in Gata4 cKO mice (D) are less 
invasive and consist exclusively of type B cells (arrowhead). Bars, 200 µm (A,B); 25 µm 
(C,D). (E-G) Shown is the relative mRNA expression (mean ± SD) of the indicated 
transcripts in OVX (n=4-8) vs. mice with intact ovaries (n=7-14) obtained from qRT-PCR 
analysis (*, P<0.05). Results are blotted on a logarithmic scale and for each gene the mean 
expression in OVX Gata4F/+ mice was set to be 1.  
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Next, we confirmed a reduced expression of GATA4 in the adrenal glands of 
ovariectomized cKO mice. By using qRT-PCR with primers specifically designed for the 
WT Gata4 mRNA the ratio of GATA4 mRNA levels between cKO and Gata4F/F mice 
was detected to be 0.20 ± 0.02 (P<0.05). Taken together this data reveals that the 
upregulation of the Amhr2-Cre transgene in nascent neoplasms of the adrenal cortex 
reduces but not entirely prevents the accumulation of neoplastic cells that express 
transcription factor GATA4.  
Finally, we evaluated whether adrenocortical tumor formation in OVX mice is 
Gata4 dose dependent by analyzing the mRNA expression levels of steroidogenic markers 
in the adrenal glands of cKO mice and controls (Figure 18E-G). As expected based on 
results obtained from B6D2F1 and B6AF1 mice (see Figure 15I), the expression of the 
prototypical adrenocortical marker Mc2r was unchanged in cKO and control mice (Figure 
18E). In contrast, mRNA levels of two gonadal-like markers Lhcgr and Inha were reduced 
in the adrenal glands of ovariectomized cKO animals when compared to control Gata4F/F 
mice (Figure 18F,G). Another gonadal-like maker Cyp17a1 was decreased in the adrenal 
glands of ovariectomized cKO mice, although this result did not reach statistical 
significance (data not shown). Generally, the OVX-induced changes in gene expression 
were more fluctuating than the results obtained from B6D2F1 and B6AF1 mice (see 
Figure 15I), possibly due to a mixed genetic background of B6.129 mice. Nevertheless, 
the data proves that the conditional deletion of Gata4F in GDX-induced, nascent 
adrenocortical tumors reduces the expression of steroidogenic gonadal-like markers in a 
GATA4 dose-dependent manner.  
Taken together, the interrelation that gonadal-like cells appear in adrenal glands of 
ovariectomized mice, due to sensitivity against Gata4 dosage, supports the presumption 
that GATA4 has a critical function during tumorigenesis. Even though it is well 
established that adrenal glands of susceptible mouse strains show a tendency for the 
formation of adrenocortical neoplasia in response to continuously elevated serum 
gonadotropin levels, the molecular mechanisms underlying this phenomenon have 
remained unclear (112, 153, 312-314) (see 1.4.3). Among other studies (316), the 
presented data offers genetic proof that transcription factor GATA4 plays a key role 
during this processes insofar as loss-of-function mutations in the Gata4 gene, either 
germline or conditional, impair OVX-induced adrenocortical neoplasia in the different 
susceptible mouse strains herein investigated. More specifically, the findings indicate that 
without an adequate dosage of GATA4, the GDX-induced changes in hormone levels 
cannot drive the formation of adrenocortical neoplasia in these strains.  
In principle, the expression of GATA4 could promote tumor initiation, the 
differentiation of sex steroidogenic cells, or tumor survival. The usage of cKO mice, in 
which the deletion of Gata4F occurs after the upregulation of Amhr2-Cre, separates the 
effects of GATA4 on tumor initiation from its impact on advanced stages, including 
gonadal-like differentiation and the proliferation or survival of neoplastic cells. The fact 
that the results obtained from Gata4 haploinsufficient mice are conserved in the cKO 
phenotype suggests that the deficiency of this transcription factor directly impacts sex 
steroidogenic differentiation or tumor growth/survival. The finding that both, germline 
haploinsufficient mice and cKO mice, exhibit paucity of type B cells and the absence of 
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ectopic estrogen production in Gata4+/- mice support the premise that GATA4 depletion 
disrupts GDX-induced tumorigenesis via the inhibition of sex-steroidogenic 
differentiation in the neoplastic tissue.  
These findings have additional implications for gonadotropin-dependent 
adrenocortical tumors in other species, including humans. Although rare, there are reports 
on adrenocortical neoplasms that resemble the histological features seen in luteinized 
ovarian stroma found in postmenopausal women (172, 317) and men with acquired 
testicular atrophy (173). The basal expression of Lhcgr in the human adrenal cortex is low, 
but it is functionally active during high gonadotropin states, including pregnancy (318). 
Based on these investigations it has been speculated that the responsiveness of the human 
adrenal gland to LH contributes to tumorigenesis and that this contribution is influenced 
by modifier genes (318, 319). 
Although in function and structure distinct, the adrenal cortex and gonads arise from 
the same pool of progenitors during embryonic development. Until now it is not fully 
understood which factors dictate whether these precursors adopt the adrenocortical or 
gonadal phenotype. The evident switch from corticoid production to sex steroid 
production seen in GDX-induced neoplasia, together with our results premise that GATA4 
is a key regulator of sex steroidogenic cell specification. We propose that GATA4 
determines the functional identity and phenotypical features of sex steroidogenic Leydig 
cells in the testis and tested this hypothesis (III and the following chapter).  
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4.2 GATA4 depletion in somatic cells of the testis (III & IV) 
Transcription factor GATA4 is found in somatic cell types of the mammalian adult testis 
and has been implicated in the development and function of this reproductive organ (36, 
130). Promoter analyses and other investigations identified a series of putative target 
genes within the testis. Among these candidates are genes associated with sex 
determination (Sry, Sox9, and Dmrt1) (116, 320, 321), gonadotropin signaling (Lhcgr and 
Fshr), sex steroid biosynthesis (Cyp11a1, Cyp17a1 and Star) (116, 124, 125, 322, 323), 
peptide hormone production (Inha, Inhba, and Amh) (122), and cell-cell interactions 
[Clmp (CXADR-like membrane protein), Cldn11, and Cx30.2] (243, 244, 246).  
Mice with germline deficiency for Gata4 die during embryonic development, 
limiting their merit to study the role of this transcription factor in LC and SC function (43, 
44). Conditional mutagenesis studies revealed that GATA4 is required for proper genital 
ridge development, testis cord morphogenesis, and SC function in the adult testis (113, 
117, 246). However, cellular heterogeneity, compensatory responses, and other factors 
hamper the interpretation of conditional knockout studies and detailed cooperation of 
GATA4 with signaling pathways and ultimate target genes are not well understood (130). 
Results obtained from genetically engineered mice to understand the role of GATA4 in 
LC function remain controversial due to inconsistent phenotypes. For example, GATA4 
depleted progenitors in chimeric mice experience a limited capability to differentiate into 
fetal LCs (130, 277). In contrast, the conditional mutagenesis of Gata4 in LCs as early as 
E12.5 does not alter the expression profile of differentiation markers in the fetal or adult 
testis (117, 130).  
To circumvent the described limitations in the interpretation of GATA4 mutagenesis 
studies we used less complicated experimental models: We assessed the impact of 
GATA4 deficiency in the LC line mLTC-1, the SC line TM4 and primary cultures of these 
adult somatic cell types.  
4.2.1 siRNA-mediated GATA4 depletion in somatic testicular cell lines  
To inhibit Gata4 expression in mLTC-1 and TM4 cells we used siRNA technology. 
Transfected siRNA interferes with the expression of specifically targeted genes by causing 
mRNA breakdown after transcription, resulting in no translation. To evaluate the 
efficiency of Gata4 gene silencing in mLTC-1 and TM4 cells RNA and protein were 
isolated 72 hours post siRNA transfection (Figure 19). Gata4 mRNA levels were reduced 
by 80 ± 8% in mLTC-1 cells (Figure 19A) and 78 ± 3% in TM4 cells (Figure 19E) 
treated with Gata4 (G4) siRNA vs. nontargeting (NT) siRNA (n=3-4, P<0.01). Western 
blot analysis detected only a trace of residual GATA4 protein in G4 siRNA treated 
samples of both cell lines (Figure 19B,F). Immunostaining of Gata4 silenced cells 
(Figure 19D,H) confirmed the efficiency of gene silencing and showed markedly reduced 
GATA4 positive cells when compared to controls (Figure 19C,G).  
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Figure 19  siRNA-mediated inhibition of Gata4 in mLTC-1 and TM4 cells. Cells were transfected 
with nontargeting (NT) or Gata4 (G4) targeting siRNA and the efficiency of gene silencing 
was assessed 72 hours later. (A) and (E), qRT-PCR was used to quantify relative Gata4 
mRNA levels (presented as mean ± SD; **,P<0.01, n=3-4). (B) and (F),Western blots of 
mLTC-1 and TM4 cell derived protein reveal only a trace of residual GATA4 protein in G4 
siRNA treated cells. Actin antibody was used as control. (C,D,G,H), Immunocytochemistry 
staining for GATA4 of cells exposed to NT siRNA or G4 siRNA. Hematoxylin was used for 
counterstaining. Bars, 15 µm (C,D) and 50 µm (G,H) 
4.2.1.1 Global transcriptomic changes 
To assess the consequences of Gata4 gene silencing on the transcriptome of mLTC-1 and 
TM4 cells microarray hybridization analysis was performed with RNA obtained from cells 
72h post transfection with either Gata4 or NT siRNA, respectively. Analysis of mLTC-1 
cells revealed a total of 3495 differentially expressed probes, including 1740 upregulated 
and 1755 downregulated genes. The complete data set is available online and accessible 
via Gene Expression Omnibus (GEO) number GSE63320. Results obtained from TM4 
cells are available via GEO number GSE74471 and this analysis identified 2414 probes 
with differential expressed profiles (1230 up- and 1184 downregulated). 
To identify biological processes and pathways affected following Gata4 gene 
silencing in the individual cell lines we performed Gene Ontology (GO) analysis and 
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis with all 
differentially expressed probes (Table 5). For mLTC-1 cells GO analysis identified 
various terms associated with the main function of LCs, sex steroid production 
(differentiation, steroid biosynthetic process, regulation of endocrine process, and 
response to hormone stimulus). KEGG pathway analysis additionally suggested 
implications in a series of metabolic pathways including pyruvate metabolism, fatty acid 
metabolism, and glycolysis/gluconeogenesis for this cell line. Among the terms identified 
using the same gene set enrichment analysis for the other cell line (TM4) revealed terms 
associated to focal adhesion, ECM receptor interaction, adherens junctions, and 
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extracellular structure organization. Interestingly, all of these processes are linked to BTB 
function (197, 204, 206) and the integrity of this barrier is disturbed in Gata4 cKO mice 
(246). These mice suffer from germ cell loss, testicular atrophy, and infertility possibly 
due to a dysfunctional BTB after GATA4 loss.  
In the following chapters we will explore the disruptions in cellular metabolism, 
steroid biosynthesis, and BTB functionality seen in LCs and SCs following GATA4 
depletion in more detail.  
 
Table 5 Gene set enrichment analysis of GATA4 depleted mLTC-1 and TM4 cells 
 
4.2.1.2 Global metabolomic changes 
Next, we assessed the consequences of GATA4 deficiency in mLTC-1 and TM4 cells on 
metabolism. Using LC-MS/MS technology we quantified a total of 96 (mLTC-1) or 110 
(TM4) intracellular metabolites. Unsupervised principle component analysis revealed a 
separation of the sample set (n=3 for mLTC-1 cells or n=4 for TM4 cells) into 2 distinct 
groups based on the metabolic profile of each individual sample (Figure 20A,B). 
These results confirmed that both cell lines show an altered metabolic profile as 
response to GATA4 depletion. All metabolomics data was subsequently used to identify 
biologically meaningful patterns at a pathway level via quantitative enrichment analysis 
Cell line Analysis Term Size * # of genes ** P Value
Steroid biosynthetic process 132 5 1.9 E-04
Sex differentiation 212 6 2.1 E-04
Regulation of endocrine process 32 3 2.9 E-04
Reproductive system development 234 6 3.7 E-04
Terpenoid backbone biosynthesis 14 9 1.1 E-05
Pyruvate metabolism 43 16 5.2 E-05
Fatty acid metabolism 48 15 8.0 E-04
Valine, leucine and isoleucine degradation 50 15 1.3 E-03
Fructose and mannose metabolism 37 12 1.8 E-03
Glycolysis / Gluconeogenesis 62 15 1.2 E-02
Alanine, aspartate and glutamate metabolism 33 9 2.2 E-02
Arginine and Proline metabolism 54 12 4.2 E-02
Cadherin binding 23 2 4.0E-02
Extracellular structure organization 161 4 4.6E-03
L-Lactate-dehydrogenase activity 3 1 1.2E-02
Lactate Metabolic Process 7 1 2.9E-02
Protein localization to extracellular region 3 1 1.2E-02
Extracellular region 1813 14 1.2E-02
Proteinaceous extracellular matrix 333 5 1.1E-02
Focal adhesion 200 42 2.2E-06
Metabolic pathways 1184 163 3.7E-06
ECM- receptor interaction 86 19 7.1E-04
D-Glutamine and D-glutamate metabolism 3 2 2.8E-02
Adherens junction 75 13 3.5E-02
Glycolysis / Gluconeogenesis 62 11 4.3E-02
Results obtained from Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis are 
 * Size describes the overall number of genes related to one specific term analysis within this group
** # of genes is the number of genes significant changed in microarray 
Gene Ontology
mLTC-1
TM4
Gene Ontology
KEGG Pathway
KEGG Pathway
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(QEA). Between the two sample groups of mLTC-1 cells a total of 25 pathways were 
identified to be significantly altered (n=3; P<0.05; FDR<0.05). Glycolysis was determined 
to be most altered pathway in this cell line. In the case of TM4 cells the number of altered 
pathways reached 33 (n=4; P<0.05; FDR< 0.05) and a variety of nucleoid acid metabolic 
pathways were identified to be changed in GATA4 depleted cells. Figure 20C and D 
show significantly altered pathways of interest, sorted by their fold change (FC). 
 
Figure 20  Impaired metabolic profiles in mLTC-1 and TM4 cells after GATA4 depletion. 72 h post 
transfection 96 (mLTC-1; n=3) or 110 (TM4; n=4) metabolites were analyzed for each 
sample group (Gata4 siRNA vs. nontargeting siRNA) using LC-MS/MS. (A,B), Unsupervised 
principal component (PC) analysis revealed a separation of the 2 sample groups of both cell 
lines based on differences in their metabolic profiles. (C,D), Consequent quantitative 
enrichment analysis (QEA) revealed significantly altered pathways (P<0.05) which are 
presented according to their fold enrichment. Shown is a subset of significantly altered 
pathways that are relevant for subsequent studies.  
Collectively, these studies in both cell lines, mLTC-1 and TM4, establish global 
transcriptomic and metabolomics changes after GATA4 depletion. However the putative 
disruptions in cellular metabolic processes, hormone production or BTB function await 
additional functional studies and are explored in the following.  
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4.3 Consequences of GATA4 deficiency in Leydig cells (III) 
4.3.1 Impact on steroidogenesis 
The results obtained from global transcriptome and metabolomic studies in mLTC-1 cells 
suggested disturbances in sex steroid production. To validate those findings we performed 
qRT-PCR analysis on RNA isolated 72 h post siRNA transfection. However, the mLTC-1 
cell line does not express the final enzyme of testosterone biosynthesis, Hsd17b3 (324). 
Consequently the mLTC-1 cell line does not produce and secrete this sex steroid and does 
not entirely recapitulate all features of the endogenous LC population. Thus we assessed 
the impact of GATA4 depletion also on primary cultures of adult LCs, rather than relying 
exclusively on the results obtained from mLTC-1 cells. To inhibit Gata4 expression in 
primary LCs we harvested the testes form adult Gata4F/F animals and subsequently 
isolated the cells of interest using percoll gradient centrifugation (283). The isolated 
Gata4F/F primary Leydig cells (pLCs) were then exposed to Cre-medicated recombination 
in vitro. pLCs were either exposed for 48 hours to a cre-expressing adenovirus (Ad-cre 
IRES-GFP) or a virus expressing the control vector (Ad-GFP). Reaching an infection 
efficiency of 95% qRT-PCR analysis revealed a 50 ± 7 % inhibition of Gata4 (n=4; 
P<0.01).  
Among the significantly decreased expression levels validated via qRT-PCR were 
genes implicated in sex steroid production (Figure 21). The mRNA levels of the entire set 
of genes encoding for testosterone biosynthetic pathway enzymes [Cyp11a1, Hsd3b1, 
Cyp17a1, Srd5a (steroid 5 alpha-reductase 1), and Hsd17b3] converting cholesterol to 
testosterone were significantly altered (Figure 21A-E). Unexpectedly, the final gene in 
the testosterone biosynthetic pathway, Hsd17b3, not detectable in mLTC-1 derived 
microarray and qRT-PCR samples, was markedly upregulated in the conditional knockout 
pLCs (Figure 21E). One possibility is that GATA4 directly regulates the expression of 
this gene or that the upregulation is a compensatory effect caused by another factor. A 
candidate for this factor is estrogen, since mice harboring a null mutation in the estrogen 
receptor-α gene exhibit dysregulation of the Hsd17b3 gene (325).  
Other dysregulated genes important for the sex-steroidogenic function of LCs were 
Nr5a1 (or Sf1), Lhcgr and Star (Figure 21F-H). Echoing our findings, other investigators 
found that Gata4 knockdown in another mouse LC line (MA-10) resulted in a reduced 
gene expression of steroidogenic markers, including Cyp11a1, Hsd3b1, and Star (326).  
Of importance, the relative expression of insulin-like 3 (Insl3), a hormone secreted by LCs 
was unchanged between GATA4 knockdown cells and controls (III). INSL3 is an 
established marker for LC function and its equal mRNA levels suggest that observed 
changes in sex steroidogenic genes are a direct consequence of GATA4 depletion and do 
not reflect cytotoxicity (327).  
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Figure 21 Impacts of GATA4 depletion on sex steroidogenic gene expression and biosynthesis of sex 
steroid precursors in LCs. (A-H), Each panel shows the relative mRNA expression of the 
indicated gene, as defined by 3 distinct methods: 1) Microarray analysis (Method 1, Array) 
of mRNA derived from mLTC-1 cells 72 h post siRNA treatment with NT or G4 siRNA 
(n=3); 2) qRT-PCR analysis (Method 2, mLTC-1) of mRNA derived from mLTC-1 cells 72 h 
post siRNA transfection with NT or G4 siRNA (n=3-4); and 3) qRT-PCR of RNA derived 
from primary Gata4F/F LCs (Method 3, pLC) 48 h post infection with adenovirus expressing 
either Cre recombinase and GFP (Cre) or GFP alone (GFP) (n=4). Array results are 
presented as relative fold changes, and qRT-PCR results as relative expressions of the mean 
± SD. (I), Production of androgens and their precursors was determined from conditioned 
cell culture media 72 h post transfection of mLTC-1 cells with either G4 or NT siRNA. 
Levels of 17-OH pregnenolone, 17-OH progesterone, testosterone, and DHT were not 
quantifiable due to assay detection limits or double-peak appearance. **, P <0.01; * P < 
0.05. NT, nontargeting siRNA; G4, GATA4 targeting siRNA; DHEA, 
Dehydroepiandrosterone; DHT, Dihydrotestosterone ; n.q., not quantifiable.  
The changes in steroidogenic gene expression due to GATA4 loss in pLCs are 
strikingly similar to those found in Gata4 siRNA-treated mLTC-1 cells. Thus, we can 
conclude that mLTC-1 cells represent a reasonable model to study the consequences of 
GATA4 loss-of-function in adult LCs. The ensuring downstream analysis therefore was 
based on mLTC-1 cells that are easier to maintain in high cell numbers and experimentally 
more easily accessible than pLCs. 
To investigate if the altered gene expression in sex steroidogenic enzymes found in 
mLTC-1 cells results in quantitatively different levels of sex steroid precursors we 
analyzed conditioned media of Gata4 siRNA treated cells vs. media derived from NT 
siRNA treated cells via LC-MS/MS. The media derived from GATA4 inhibited mLTC-1 
cells 72 h post transfection contained significantly lower concentrations of pregnenolone, 
progesterone, androstenedione, and androstanedione (n=3; P<0.01; Figure 21I). Based on 
these results one can state that the downregulation of sex steroidogenic gene expression in 
GATA4 depleted mLTC-1 cells is accompanied by a decreased biosynthesis of sex steroid 
precursors. Of interest, the biosynthesis of all steroids relies on lanosterol supply, that is 
produced via triterpenoid squalene cyclization (328). Of note, the terpenoid biosynthetic 
pathway was identified to be one of the most significantly altered pathways in our 
presented transcriptomic KEGG pathway Table 5.  
4.3.2 Impaired glycolytic activity 
Metabolic analysis, including the quantification of 96 metabolites in Gata4 siRNA treated 
and control mLTC-1 cells via LC-MS/MS revealed that of all significantly altered 
pathways glycolysis was the top hit (see Figure 20C). In keeping with this and results 
obtained from microarray hybridization, qRT-PCR for the glycolytic genes hexokinase 1 
(Hk1), glucose phosphate isomerase1 (Gpi1), phosphofructokinase (Pfkp), and 
phosphoglyceratemutase 1 (Pgam1) showed reduced mRNA levels in samples derived 
from GATA4 depleted mLTC-1 cells (Figure 22A-D).  
Based on these results, indicative for an impaired glycolysis in GATA4 depleted 
mLTC-1 cells, we predicted a decrease of intracellular ATP levels in the knockdown cells. 
Indeed, the loss of GATA4 in mLTC-1 cells was accompanied by a 30 ± 12% reduction in 
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intracellular ATP levels when compared to cells treated with NT siRNA (Figure 22E). 
The differences in ATP levels between the two sample groups were predominantly 
consequences of gene silencing of glycolytic enzymes, because after inhibition of 
glycolysis 72 hours after siRNA transfection with 2DG (deoxy-D-glucose) and /or DCA 
(dichloroacetic acid) the ATP levels of Gata4 siRNA treated cells were only minimally 
affected. In contrast, NT siRNA treated cells revealed significant reductions in 
intracellular ATP levels (45 ± 16%2 for DCA inhibition; and 54 ± 20% for inhibition with 
DCA and 2DG; n=4; P<0.05) after inhibition of glycolysis. 
 
 
 
 
Figure 22 Impaired glycolysis in GATA4 deficient mLTC-1 cells. (A-D), 72 h post siRNA transfection 
of mLTC-1 cells with either Gata4 (G4) or nontargeting siRNA (NT) the mRNA expression 
levels of indicated genes were analyzed using microarray hybridization (Array) or qRT-PCR 
(mLTC-1). Results are shown as relative expressions of the mean ± SD (**, P<0.001; *, 
P<0.05, n=3-8). (E), To evaluate the contribution of glycolysis to cellular ATP production 
the intracellular ATP levels were determined 72 h post siRNA transfection and inhibition of 
glycolysis with 2DG (deoxy-D-glucose) and DCA (dichloroacetic acid). Values are 
presented as the mean ± SD and for statistical analysis bars were compared to nontargeting 
siRNA treated controls in the absence of any inhibitors. (*, P<0.05; n=4). (F-H), 
Concentrations of glucose, lactate, and ammonium in conditioned media derived from 
mLTC-1 cells treated for 72 h with Gata4 or nontargeting siRNA, respectively were 
quantified with a Konelab Arena 20XT analyzer and concentrations are presented as the 
mean ± SD (**, P<0.01; n=8).  
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To further verify our findings of an affected glycolytic pathway in GATA4 depleted 
mLTC-1 cells, we quantified the concentrations of glucose, lactate, and the metabolic 
waste product ammonium in conditioned media 72 h post transfection. Consistent with our 
previous findings glucose concentrations in the media derived from Gata4 deficient 
mLTC-1 cells were significantly higher (Figure 22F), and lactate concentrations lower 
(Figure 22G) when compared to control cells. Ammonium concentrations were lower in 
cells deficient for GATA4 (Figure 22H), indicating an overall reduced metabolic activity 
in these cells. The reduced metabolic activity in GATA4 depleted cells is further 
supported by the fact that all of the 20 most significantly altered metabolites identified 
during the metabolomic analysis were decreased in GATA4 deficient cells when 
compared to control cells treated with NT siRNA (III and chapter 4.2.1.1).  
Taken together, transcriptomic and metabolomic analyses suggest that glycolysis is 
impaired in LCs lacking GATA4 transcription factor. Within this central cellular pathway 
glucose is catabolized to generate ATP, needed for biomass supply, proliferation and other 
cellular functions. Genome wide occupancy analysis performed by other investigators 
revealed that GATA4 promoter site occupancy is tissue specific. Interestingly, GATA4 
occupies promoter sites of glycolytic genes in hepatocytes but not cardiomyocytes (329). 
Evidence that a single transcription factor is capable of regulating cellular steroidogenesis, 
glycolysis, and other metabolic pathways was previously reported in the case of NR5A1 in 
Y-1 mouse adrenocortical and MA-10 Leydig tumor cells (330). The investigators 
demonstrated that this nuclear receptor controls the expression of genes necessary for ATP 
and NADPH production, both essential energy carriers and required for the de novo 
synthesis of sex steroids.  
Although there is now evidence that GATA4 plays an important role in regulating 
energy metabolism in mLTC-1 LCs, caution must be applied with conclusions regarding 
primary tissues. MA-10 tumorigenic LCs receive a high percentage of their ATP from 
glycolysis, whereas pLCs seem to be dependent on mitochondrial respiration (331). This 
altered energy metabolism is a well known hallmark of tumor cells (Warburg effect) and 
describes oxygen dependent increased glycolytic capacity in diseased cells (332). 
Consequently, the herein described changes in glycolytic activity and ATP production 
following Gata4 knockdown in mLTC-1 tumor cells may not be representative for pLCs 
or in vivo conditions. However, evidence that a GATA transcription factor can impact 
intermediary metabolism in non-tumorigenic cell was provided by a study investigating 
the conditional mutagenesis of GATA6 in murine peritoneal macrophages, resulting in 
altered expression of metabolic regulators, essential for the synthesis of acetyl coenzyme 
A (333).  
In summary, we provide genetic evidence that transcription factor GATA4 is a key 
player in the regulation of LC function, including sex steroid production and the control of 
central energy metabolic processes. Using a similar reductionist approach involving 
siRNA- or adenovirus-mediated GATA4 depletion, we explore the detailed consequences 
of GATA4 loss in SC within the following chapters. 
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4.4 Consequences of GATA4 deficiency in Sertoli cells (IV) 
4.4.1 Impaired blood-testis barrier integrity 
Sertoli cells support the maturation of germ cells during spermatogenesis by providing a 
unique microenvironment. One key component for the maintenance of this environment is 
the BTB, a dynamic framework made up of tight junctions, adherens junctions, gap 
junctions, and other protein complexes, such as desmosomes that link neighboring SC 
with each other (chapter 1.5.2). Although previous investigations in our laboratory 
revealed that the gradual deletion of transcription factor GATA4 in SCs of the adult 
mouse results in an increased permeability of the BTB (246), the exact targeted molecular 
pathways have not been well understood.  
Interestingly, KEGG pathway and GO analysis based on microarray hybridization 
data obtained from TM4 cells (chapter 4.2.1.1) identified many processes associated with 
BTB function or dynamics, including ECM receptor interactions, focal adhesion, 
extracellular structure organization and focal adhesion (197, 204, 206) (Table 5). To 
validate this data we performed qRT-PCR analysis on mRNA derived from TM4 cells 72 
h post siRNA transfection with either G4 siRNA or NT siRNA. Similarly to the 
investigations of LCs (chapter 4.3.1) we also assessed the impact of GATA4 depletion via 
adenovirus-mediated Cre recombination on primary Sertoli cell cultures (pSCs) isolated 
from Gata4F/F animals, rather than exclusively relying on siRNA-mediated silencing in 
TM4 cells. The efficiency of infection based on GFP expressing cells was determined to 
be >90% and Gata4 inhibition was determined to be 58 ± 10% 48 h post infection (n=4; 
P<0.01). Like in LCs, changes observed in gene expression following Gata4 inhibition in 
pSCs were kindred to those observed in Gata4 siRNA treated TM4 cells. These results 
implicate that TM4 cells are presenting a reasonable model for investigating the impacts 
of GATA4 deficiency on SC function. 
Using qRT-PCR on TM4 and pSC derived samples we validated that the loss of 
GATA4 was accompanied by a drop in mRNA expression levels of the tight junction 
associated genes Cldn12 and Tjp1 (Figure 23A,B). Those transmembrane proteins are 
implicated in BTB function (chapter 1.5.2). Of interest, other members of the claudin 
protein family (Cldn2 and Cldn11) are regulated through GATA transcription factors 
(223, 334, 335).  
Although not identified to be differentially expressed by microarray hybridization, 
Cx30.2, was found to be downregulated in Gata4 inhibited TM4 cells as well as in pSCs 
(Figure 23C). This gene encodes for a gap junction protein that is thought to mediate 
interactions between developing germ cells and SCs (336) (chapter 1.5.2). In the heart 
Cx30.2 is identified to be a downstream target of GATA4, and whole testis extracts 
derived from Gata4 cKO mice show decreased mRNA expression levels when compared 
to control mice (246).  
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Furthermore, genes associated with the formation of the apical ES (337), including 
c-Src tyrosine kinase (Csk) were downregulated following GATA4 depletion in 
manipulated SC cultures (Figure 23D). Functional apical ES is essential during 
spermatogenesis and spermiogenesis because it prevents the release of immature, not fully 
developed spermatozoa into the lumen of the seminiferous tubule (chapter 1.5.2). Of note, 
SC specific Gata4 cKO mice exhibit this phenotypical feature and the premature release 
of spermatocytes and spermatids has been described in the literature (246). 
The loss of GATA4 in TM4 and pSCs was further accompanied by changed mRNA 
levels of markers known to be involved in the regulation of BTB integrity and remodeling 
during spermatogenesis [reviewed in (206) and chapter 1.5.2]. Among others, these 
include ECM proteins [laminin1 (Lamc1), type IV collagens (Col4a5), proteases (matrix 
metalloproteinase 23 (Mmp23)], and cytokines (TNF) (Figure 23E-H). Previous 
published studies report a decrease in laminin and type IV collagen expression levels in 
embryoid bodies derived from embryonic stem cells that are germline deficient for Gata4, 
provide independent evidence that the lack of GATA4 affects ECM gene expression 
(338). Furthermore, the dysregulations observed in the gene expression of Mmp23 
following GATA4 loss in TM4 and pSCs are in line with studies showing altered mRNA 
levels of this tissue-remodeling protein in ovaries of double Gata4/Gata6 cKO mice (339). 
Although not detected in the microarray, the upregulation of TNF is of particular interest 
since this cytokine is reported to be released when ECM proteins are degraded (230). TNF 
is known to perturb SC tight junction formation in a dose-dependent manner and Gata4 
cKO mice with increased BTB permeability exhibit elevated Tnf gene expression (207, 
246). Of particular interest is also that TNF is described to stimulate the production of 
lactate in SCs (340), advocating a link between ECM-SC interactions and lactate 
biosynthesis in these cells. 
Spurred by the diminished expression of Tjp1 after GATA4 loss in TM4 cells and 
pSCs we investigated protein levels of TJP1 72 h post siRNA transfection (TM4 cells) or 
48 h post adenoviral infection (pSCs) via Western blotting (Figure 23I). Whereas the 
levels of the housekeeping protein Actin were the same in both sample groups, there were 
reduced amounts of TJP1 protein detected in GATA4 depleted cells. This was true for 
both TM4 cells and pSCs.  
 
  
RESULTS AND DISCUSSION 
 70 
 
  
RESULTS AND DISCUSSION 
 71 
 
Figure 23  Impact of GATA4 loss on blood-testis barrier (BTB) function. (A-H), Each panel shows 
the relative mRNA expression of the indicated gene, as defined by 3 distinct methods: 1) 
Microarray analysis (Method 1, Array) of mRNA derived from TM4 cells 72 h post siRNA 
treatment with NT or G4 siRNA (n=3); 2) qRT-PCR analysis (Method 2, TM4) of mRNA 
derived from TM4 cells 72 h post siRNA transfection with NT or G4 siRNA (n=4); and 3) 
qRT-PCR of RNA derived from primary Gata4F/F SCs (Method 3, pSC) 48 h post infection 
with adenovirus expressing either Cre recombinase and GFP (Cre) or GFP alone (GFP) 
(n=4). Array results are presented as relative fold changes, and qRT-PCR results as relative 
expressions of the mean ± SD. (I), Western blotting revealed reduced protein levels of TJP1 
were determined 72 h post siRNA transfection (TM4 cells) or 48 h post adenoviral infection 
(pSCs). Actin antibody was used as control. (J-M), Electron micrographs of TM4 cells 
grown on matrigel 72 h post siRNA transfection with either G4 or NT siRNA. Panels L and 
M represent higher magnification views of boxed areas in panels J and K, respectively. 
Bars, 500 nm. (N) TM4 cells transfected with indicated siRNA (n=3) were grown on 
matrigel coated bicameral units and epithelial barrier permeability was assessed by 
measuring the trans-epithelial resistance (TER) at indicated time points. TER values are 
expressed as the mean ± SD. **, P <0.01; * P < 0.05. NT, nontargeting siRNA; G4, GATA4 
targeting siRNA; N.A., not available; d, desmosome; v, vacuole. 
To further explore the importance of transcription factor GATA4 in BTB formation 
we next assessed the ultrastructural appearance of TM4 cells treated with G4 or NT 
siRNA, respectively. For this intention TM4 cells were siRNA transfected, cultured for 72 
hours on slides that were coated with matrigel, and then processed for electron microscopy 
(Figure 23J-M). Samples obtained from NT siRNA treated TM4 cells exhibited cell-cell 
contacts, such as desmosomes (arrowheads in Figure 23L). In contrast, even thought 
adjacent TM4 cells were aligned close to each other and their cellular membranes were 
juxtaposed G4 siRNA treated TM4 cells did not show any signs of cell-cell junctional 
contacts (Figure 23K,M). No morphological signs of apoptosis (condensation of 
chromatin) were present, but there were high numbers of vacuoles in the GATA4 depleted 
TM4 cells observed (Figure 23K,M). This observation is in line with the phenotypical 
appearance of Gata4 cKO mice that also exhibit SC vacuolation (246).  
To assess the consequences on epithelial barrier function in a functional setting the 
trans-epithelial resistance (TER) built up by functional cell-cell contacts between adjacent 
SCs was measured. TER is a widely accepted indicator of a functional paracellular barrier 
to ion conductance (286). To determine TER TM4 cells were transfected and grown on 
matrigel coated bicameral units. By day three in culture there was a significant difference 
in TER value measured between the two sample groups (G4 siRNA vs. NT siRNA treated 
cells) (Figure 23N). GATA4 depleted TM4 cells continued to have a remarkably reduced 
TER until day 6.5 when compared to controls.  
In summary, the presented results implicate GATA4 in the regulation of several 
genes associated with BTB function. We further present functional evidence that GATA4 
is important to maintain epithelial barrier integrity and TER. 
 
  
RESULTS AND DISCUSSION 
 72 
4.4.2 GATA4 regulates Sertoli cell lactate metabolism 
In addition of providing the structural framework to facilitate spermatogenesis, SCs also 
produce and secrete essential nutrients for the trophic support of developing germ cells. To 
fulfill the energy needs of these cells, the biosynthesis of lactate via glycolysis and 
glutaminolysis is a fundamental feature of SC physiology and function.  
Both, KEGG pathway and GO term analyses of Gata4 inhibited TM4 cells revealed 
statistically significant changes in pathways important for lactate and glutamate 
metabolism. Among the identified key pathways were glycolysis, L-lactate-dehydrogenase 
activity, D glutamine and D-glutamate metabolism, and lactate metabolic process (see 
Table 5; chapter 4.2.1.1). To validate those results qRT-PCR analysis of GATA4 deficient 
TM4 and pSCs was performed. In this experiment the downregulation of all glycolytic 
enzymes (Hk1, Gpi1, Pfkp, and Pgam1) was confirmed (Figure 24A-D) and this is in line 
with the previously described finding of a diminished glycolytic activity in response to 
GATA4 deficiency in LCs (see Figure 22; chapter 4.3.2). 
Of interest, the mRNA levels of genes essential for the regulation of PDC activity 
[Pdk3 and -4 (pyruvate dehydrogenase kinase, isoenzyme 3 and 4)] were found to be 
altered in TM4 and pSCs following GATA4 depletion using siRNA or Cre-recombination 
in vitro (Figure 24E-F) The presence and activity of these kinases determines whether 
pyruvate is metabolized via TCA cycle or if it is converted into lactate (see Figure 9 and 
Figure 25) (341). The status of PDC activity is tightly regulated by a mechanism 
involving reversible phosphorylation of PDC by PDK isoforms (341). Phosphorylation is 
associated with an inactive state, whereas dephosphorylation through pyruvate 
dehydrogenase phosphatase (PDP) results in an active state. As a consequence, the 
activities of both, PDK and PDP, regulate the entry of pyruvate into the TCA cycle. 
Interestingly, FSH is known to boost lactate production through the upregulation of Pdk3 
and concomitant downregulation of Pdk4 (259). The reciprocal findings of dysregulation 
in these genes after GATA4 depletion suggest a diminished lactate production and that 
this condition mimics the phenotypical changes associated to FSH withdrawal.  
Although not fully characterized, the biosynthesis of lactate, via the degradation of 
amino acids, has been discussed as a principal feature of SCs (192). Especially glutamine 
via glutaminolysis, serves as an alternative to glucose for the biosynthesis of lactate. The 
first step of glutaminolysis represents the conversion of glutamine to glutamate. This step 
is catalyzed by glutaminase 2 (Gls2), found to be downregulated in both GATA4 depleted 
TM4 and pSCs (Figure 24G).  
A diminished lactate production in SCs lacking transcription factor GATA4 is 
further supported by a downregulation of Ldhb (Figure 24H). The last step in the 
biosynthesis of lactate is the conversion of pyruvate into lactate, which is catalyzed by 
LDH (see Figure 9 and Figure 25). This tetramer is composed of LDHA and LDHB 
subunits, whereas the combination of these subunits results in 5 different isoenzymes 
(342). Research suggests that LDHA is the major LDH subunit in SCs (190), however 
LDHB is expressed in this cell type (342, 343). It remains to be determined if the decrease 
of Ldhb expression in GATA4 deficient SCs has comparable physiological consequences 
as a stable Ldha expression.  
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Additionally, metabolic analysis (partial least square discriminant analysis followed 
by QEA) identified glutamine to be the metabolite exhibiting the largest change in TM4 
cells treated with Gata4 siRNA when compared to controls (Figure 24I). Intracellular 
glutamine levels were 2.3-fold enriched in GATA4 depleted cells, indicating that this 
metabolite is no longer used via glutaminolysis to support lactate production. Under 
normal conditions, the conversion of this amino acid into lactate is reported to yield a 
huge proportion of the energy required by this cell type (258). A reasonable explanation 
for the elevated glutamine levels, found in GATA4 depleted cells, is offered by a 
decreased expression of Gls2 in these cells. Glutamine is known to hamper alanine 
incorporation during protein synthesis (258), and consequently the levels of this amino 
acid were increased in cells lacking GATA4 (Figure 24I). This feature is of high 
importance in SCs because alanine can be converted into lactate and serves as another 
substrate to maintain high lactate production. The lack of GATA4 additionally increased 
the levels of other amino acids, including serine, glycine, threonine, asparagine, and 
aspartate. Similarly as alanine, those amino acids can serve under normal conditions as 
alternative sources in SC metabolism and their accumulation is an indicator of inhibited 
cellular metabolism. The lower concentrations of the metabolic waste product ammonium 
(Figure 24J) in the cell culture media of Gata4 siRNA treated cells compared to control 
levels further suggested an overall reduced metabolic activity in these cells. 
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Figure 24  Impact of GATA4 loss on lactate metabolism. (A-H), Each panel shows the relative mRNA 
expression of the indicated gene, as defined by 3 distinct methods: 1) Microarray analysis 
(Method 1, Array) of mRNA derived from TM4 cells 72 h post siRNA treatment with NT or 
G4 siRNA (n=3); 2) qRT-PCR analysis (Method 2, TM4) of mRNA derived from TM4 cells 
72 h post siRNA transfection with NT or G4 siRNA (n=4); and 3) qRT-PCR of RNA derived 
from primary Gata4F/F SCs (Method 3, pSC) 48 h post infection with adenovirus expressing 
either Cre recombinase and GFP (Cre) or GFP alone (GFP) (n=4). Array results are 
presented as relative fold changes, and qRT-PCR results as relative expressions of the mean 
± SD. (I), A total of 110 metabolites were analyzed from TM4 cells 72 h post siRNA 
transfection using mass spectrometry (n=4). Subsequent partial least squares discriminant 
analysis identified glutamine as the most dramatic altered metabolite after GATA4 
depletion. Metabolites are listed according to their variable of importance (VIP) and 
relative magnitudes of disturbance indicated on the right with red (increase) or green 
(decrease.) (J-L), Levels of glucose, lactate, and ammonium in conditioned media derived 
from TM4 cells treated for 72 h with G4 or NT siRNA (n=8), were quantified with a 
Konelab Arena 20XT analyzer and concentrations are presented as the mean ± SD.**, P 
<0.01; * P < 0.05. NT, nontargeting siRNA; G4, GATA4 targeting siRNA.  
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Subsequently, and in keeping with previous results, the concentration of lactate was 
significantly lower in the conditioned media derived from GATA4 depleted TM4 cells 
than in the media derived from controls (Figure 24K). In contrast, glucose levels were 
significantly elevated (Figure 24L). Lactate secreted by SCs is the major energy source 
for mature germ cells, that have passed the BTB during spermatogenesis, and this 
metabolite has a stimulating effect on RNA and protein biosynthesis in spermatids (344). 
Consequently, a diminished lactate production has profound impacts on the development 
of germ cells. Testicular lactate levels of cryptorchid rats are low and the local infusion of 
this metabolite supports spermatogenesis in these animals (253). Lactate is also known to 
have antiapoptotic effects on mature germ cells in the testis (254) and in summary the 
presented results provide evidence that the apoptosis of haploid germ cells seen in Gata4 
conditional knockout mice (246) is not only a consequence of a dysfunctional BTB but at 
least in part also a result of insufficient supply of SC-derived lactate. 
Collectively, the presented research manifests the assumption that silencing of 
Gata4 in SC is associated with the loss of the Warburg phenotype that normally typifies 
cell metabolism of this testicular cell type. The identified transcriptomic and metabolomic 
consequences inhibiting lactate production in SCs lacking GATA4 are illustrated and 
summarized in Figure 25. 
 
Figure 25 Diminished lactate production in GATA4 depleted SCs. Transcriptomic and metabolomic 
consequences of GATA4 loss in SCs are illustrated. In summary, SCs deficient for 
transcription factor GATA4 exhibit transcriptional changes of genes of all major regulatory 
steps important for shunting glucose to lactate: 1) glycolytic enzymes (converting glucose to 
pyruvate; Hk1, Gpi1, Pfkp, Pgam1), 2) PDC (regulating the entry of pyruvate into the TCA 
cycle; Pdk3/4), 3) LDH (converting pyruvate to lactate; Ldhb) and 4) enzymes regulating 
glutaminolysis (Gls2). Modified from (192). 
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5. Conclusions, future prospects and clinical 
implications 
This dissertation focuses on the molecular mechanisms that regulate normal and neoplastic 
steroidogenic cell development and function in the adrenal gland and testis. 
1) LCM-RRBS represents a novel method to accurately map genome-wide DNA 
methylation profiles from miniscule tissue samples. The introduction of a sample 
specific index allows parallel sample processing that results in a time- and cost-
effective method exhibiting reduced DNA loss. By applying RRBS to LCM-derived 
tissue samples we found that DNA methylation directs gene expression and the 
accumulation of neoplastic cells in the murine adrenal cortex. We identified a series 
of genes previously implicated in adrenal and gonadal development and 
differentiation, which show a significantly altered DNA methylation pattern in 
adrenocortical neoplastic tissue when compared to healthy tissue of the adrenal 
cortex. 
Because of the shared common origin of adrenocortical and gonadal cells we 
hypothesize that the detected changes in DNA methylation are induced by elevated 
LH serum levels and lead to cell fate conversion. The newly identified markers of 
neoplastic cells in the adrenal cortex may prove useful for the development of 
diagnostic testing, tumor classification and for continuous studies of steroidogenic 
cell development. 
2) Expression of transcription factor GATA4 promotes tumor formation in 
gonadectomy-induced adrenocortical neoplasms. Based on the results obtained from 
mice harboring constitutive or acquired mutations in the Gata4 gene we conclude 
that this transcription factor mitigates the accumulation of neoplastic cells in the 
adrenal cortex of ovariectomized mice. Our results establish the assumption that 
GATA4 is a direct driver of postgonadectomy adrenocortical neoplasia and is not 
only a marker of gonadal-like differentiation within these tumors.  
In the past, transcription factors were considered as inherently difficult targets 
for drug development. However, the presented work allows the hope that GATA 
transcription factors one day could be targeted pharmacologically and become 
druggable. A small molecule inhibitor targeting GATA2 has been shown to inhibit 
the growth of prostate cancer cells (345). It would be desirable to apply analogical 
approaches for a directed inhibition of GATA4 in neoplastic cells of the adrenal 
gland. 
3) Transcription factor GATA4 plays an essential role for the proper function of 
murine somatic testicular cells. Its depletion demonstrates profound effects on cell 
specific functions that cannot be compensated by other GATA family members. 
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More specifically, loss of GATA4 in testosterone producing LCs resulted in 
disturbed sex steroid production and decreased glycolytic activity. The strikingly 
altered expression of enzymes important for the testosterone synthetic pathway, 
following GATA4 depletion, could have physiological and medical ramifications. 
The guiding principle of endocrine therapy for prostate cancer is to deprive the 
neoplastic cells of androgen stimulation. Suppression of gonadal androgen 
production via chemical castration with GnRH analogues is a mainstay of treatment 
for advanced prostate cancer. Unfortunately, the most commonly used GnRH 
analogue fails to achieve castrate levels of serum testosterone in a significant 
fraction of cases (346). Of interest for the development of novel GnRH analogues 
and inhibitors of enzymes involved in androgen biosynthesis is that the paradoxical 
increase in Hsd17b3 expression was recapitulated in follow-up studies when normal 
LCs (lacking floxed alleles) were incubated with conditioned medium from Gata4 
knockout LCs. This suggests that a secreted factor mediates the process. Currently 
there is no direct evidence that human HSD17B3 is regulated in this manner. If this 
counterregulatory response also operates in human LCs, it could contribute to 
inadequate androgen suppression in patients with prostate cancer who undergo 
medical castration. Consequently, investigations in this field could improve 
urological cancer therapy. 
In the case of SCs, GATA4 depletion resulted in the loss of the Warburg 
phenotype that normally typifies cell metabolism in this cell type. This conclusion is 
based on the inhibition of a series of pathways normally favoring lactate production 
and on decreased secretion of this metabolite, essential for germ cell development. 
GATA4 exerts its metabolic effects via FSH signaling and by regulating the gene 
expression of key enzymes in lactate biosynthesis. We further conclude that GATA4 
is a crucial regulator of genes important for BTB integrity and the mediation of cell-
cell contacts, such as apical ectoplasmic specializations during spermatogenesis.  
The results described and presented in this thesis provide novel insights into 
the downstream targets of GATA4 in adult Leydig and Sertoli cells. However 
additional studies, including chromatin immunoprecipitation (ChiP) sequencing, are 
required to elucidate if GATA4 directly binds to the promoters of the genes found to 
be differentially expressed in GATA4 deficient cells or if those regulations are 
mediated through secondary effects.  
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